DE102007036183A1 - New phosphoric acid ester comprising orthophosphoric acid e.g. polyphosphoric acid, alkyloxy compound and a diol compound useful e.g. as thickener, emulsifier and dispersant, and in deodorant formulation and cosmetic composition - Google Patents

Abstract

Phosphoric acid ester (E) comprising one or more structural units derived from component A including orthophosphoric acid and one or more of its derivatives, preferably polyphosphoric acid, tetraphosphoric decaoxide, phosphoroxychloride or phosphorus pentachloride; one or more structural units from component B including one or more alkyloxy compound (I); and one or more structure units from component C including one or more diol compound (II), is new. Phosphoric acid ester (E) comprising one or more structural units derived from component A including orthophosphoric acid and one or more of its derivatives, preferably polyphosphoric acid, tetraphosphoric decaoxide, phosphoroxychloride or phosphorus pentachloride; one or more structural units from component B including one or more alkyloxy compound of formula (R 2>-O-(CH 2CH 2) u(C 3H 6O) v(DO) w-H) (I), where the groups ethylene oxide are propylene oxide are arranged and DO is blocked or statistically distributed from (I); and one or more structure units from component C including one or more diol compound of formula (HO-(CH 2CH 2O) a(C 3H 6O) b(DO) c-H) (II), where the phosphoric acid ester derived from (II) contains two or more P-atoms per molecule, is new. R 2>saturated 6-30C (preferably 12-18C) alkyl, or 6-30C (preferably 8-22C) unsaturated alkenyl, preferably alcohol from octanol, decanol, dodecanol, tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl alcohol, 8-22C fatty alcohol, preferably 10-12C fatty alcohol, 12-14C fatty alcohol, 12-15C fatty alcohol, 16-18C fatty alcohol, branched fatty alcohol, preferably guerbet alcohol, unsaturated fatty alcohols, preferably delta-9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol or cis-delta-11-octadecanol; D : saturated 4-20C alkylene group, unsaturated 4-20C alkenylene group or -CH(aryl)CH 2-, preferably -CH(phenyl)CH 2-; u : 0-200 (preferably 10-50), preferably 10-50; v : 0-100, preferably 0; either a : 0-800, preferably 20-100; and b : 0-100, preferably 0; and c : 0-100, preferably 0; or a+b+c : greater than or equal to 1, preferably 5-150; and w : 0-100, preferably 0. An independent claim is included for a cosmetic-, pharmaceutical- or dermatological composition (G) comprising (E).

Description

The Invention relates to esters of phosphoric acid or phosphoric acid derivatives, Fatty alcohol, which is optionally alkoxylated, and diol, and their use as associative thickeners, especially in cosmetic, pharmaceutical or dermatological compositions.

At Cosmetic products are made high demands. You should show a clear appearance, toxicologically and ecotoxicologically be safe, produce a pleasant skin feeling and an excellent have rheological behavior over a wide pH range is constant.

Water- or solvent-containing Multi-component systems such as emulsions or suspensions often become economical Establish, for application reasons or for stability reasons higher viscosities set or thickened.

So can e.g. by raising the viscosity the external or internal phase of emulsions or suspensions be achieved that the time to demixing the components of such a system can be significantly extended, resulting in in an extension the storage time noticeable. By increasing the viscosity will also for many products their uniform distribution in particular on uneven surfaces improved.

By the more even distribution and extended Duration of action is thus increased the effectiveness. In addition to the mentioned application technology The high viscosity of such preparations also offers further advantages Advantages in the production, packaging, filling and storage as well as in the Transport.

In The specialized literature will be a variety of different systems indicated to the rheological properties of aqueous or solvent-containing Adjust systems, emulsions or suspensions. Are known for example, cellulose ethers and other cellulose derivatives (e.g. Carboxymethylcellulose, hydroxyethylcellulose), gelatin, starch and Starch derivatives, Sodium alginates, fatty acid polyethylene glycol esters, Agar-agar, tragacanth or dextrine. As synthetic polymers come various materials are used, such as polyvinyl alcohols, Polyacrylamides, polyacrylic acid and various salts of polyacrylic acid, polyvinyl pyrrolidone, polyvinyl methyl ether, Polyethylene oxides, copolymers of maleic anhydride and vinyl methyl ether, as well as various mixtures and copolymers from the above Links.

The However, these compounds show various disadvantages in the application. Thus, e.g. the cellulose derivatives or generally the natural ones Raw materials based materials and the resulting Formulations very vulnerable against bacteria. From an application point of view, they mostly fall through education unpleasant, "thread pulling "gels on. Fettsäurepolyethylenglykolester tend to hydrolysis in the presence of water, the resulting insoluble fatty acids cause unwanted Opacities. thickener natural Origin (e.g., agar-agar or tragacanth) are different depending on the origin a strongly fluctuating composition.

US 5,129,462 describes shampoo formulations comprising polyethylene glycol polyol fatty acid esters, in particular PEG pentaerythritol fatty acid esters as thickeners. The processing and formability of this class of compounds is impaired by their high melting points or pour points.

EP 1 518 900 and EP 1 344 518 disclose cosmetic and pharmaceutical preparations containing alkoxylated polyglycerol esters as thickeners, dispersants for aqueous, aqueous-alcoholic and aqueous-surfactant preparations and as emulsifiers, suspending agents with thickening effect and consistency regulator for emulsions and suspensions.

The have associative thickeners described in the cited documents on the one hand still potential for improvement in terms of their thickening performance, especially in purely aqueous systems, where they are just cloudy gels but also in terms of stability at low pH. at pH values below 5 are not their gels and thickened surfactant solutions stable on storage but lose viscosity very quickly.

task The invention was therefore to a novel class of substances available ask for the Use in cosmetic products is suitable in the formulations gives a clear appearance and also in a strongly acidic Medium a high thickening power caused by temperature load and long storage times and this Properties combined with excellent thickening performance.

It was surprising found that solved this task is replaced by esters of phosphoric acid or Esters of phosphoric acid derivatives with optionally alkoxylated fatty alcohols, characterized are that the phosphorus atoms over Groups derived from diols are bridged.

• A) eine oder mehrere Struktureinheiten abgeleitet von Substanzen der Komponente a), wobei die Substanzen der Komponente a) ausgewählt sind aus Orthophosphorsäure und einem oder mehreren ihrer Derivate, und wobei das eine oder die mehreren Derivate der Orthophosphorsäure vorzugsweise ausgewählt sind aus Polyphosphorsäure, Tetraphosphordecaoxid, Phosphoroxychlorid und Phosphorpentachlorid,
• B) eine oder mehrere Struktureinheiten abgeleitet von Substanzen der Komponente b), wobei die Substanzen der Komponente b) ausgewählt sind aus einer oder mehreren Verbindungen der Formel (I) R²-O-(CH₂CH₂O)_u(C₃H₆O)_v(DO)_w-H (I)worin R² für eine lineare oder verzweigte, gesättigte Alkylgruppe mit 6 bis 30, vorzugsweise 8 bis 22, besonders bevorzugt 12 bis 18 Kohlenstoffatomen, oder für eine lineare oder verzweigte, ein- oder mehrfach ungesättigte Alkenylgruppe mit 6 bis 30, vorzugsweise 8 bis 22, besonders bevorzugt 12 bis 18 Kohlenstoffatomen, steht, D für eine lineare oder verzweigte gesättigte Alkylengruppe mit 4 bis 20 Kohlenstoffatomen, für eine lineare oder verzweigte ein- oder mehrfach ungesättigte Alkenylengruppe mit 4 bis 20 Kohlenstoffatomen oder für -CH(Aryl)CH₂-, vorzugsweise -CH(Phenyl)CH₂-, steht, u für eine Zahl von 0 bis 200, vorzugsweise von 2 bis 150, besonders bevorzugt von 5 bis 100, insbesondere bevorzugt von 10 bis 50, steht, v für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 50, besonders bevorzugt von 0 bis 20, steht, w für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 20, besonders bevorzugt von 0 bis 10, steht, und wobei die Gruppen CH₂CH₂O, C₃H₆O und DO aus den Verbindungen der Formel (I) blockartig oder statistisch verteilt angeordnet sein können, und
• C) eine oder mehrere Struktureinheiten abgeleitet von Substanzen der Komponente c), wobei die Substanzen der Komponente c) ausgewählt sind aus einem oder mehreren Diolen der Formel (II) HO-(CH₂CH₂O)_a(C₃H₆O)_b(DO)_c-H (II)worin D die Bedeutung wie in Formel (I) hat, a für eine Zahl von 0 bis 800, vorzugsweise von 0 bis 250, besonders bevorzugt von 10 bis 200 und insbesondere bevorzugt von 20 bis 100, steht, b für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 50, steht, c für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 20, steht, wobei die Summe a + b + c ≥ 1, vorzugsweise von 5 bis 150, ist, und die Gruppen CH₂CH₂O, C₃H₆O und DO aus den Verbindungen der Formel (II) blockartig oder statistisch verteilt angeordnet sein können und die Phosphorsäureester 2 oder mehr über eine Struktureinheit abgeleitet von den Verbindungen der Formel (II) verbrückte P-Atome pro Molekül enthalten.

The present invention therefore provides phosphoric acid esters containing

• A) one or more structural units derived from substances of component a), wherein the substances of component a) are selected from orthophosphoric acid and one or more of its derivatives, and wherein the one or more derivatives of orthophosphoric acid are preferably selected from polyphosphoric acid, tetraphosphorodecoxide, Phosphorus oxychloride and phosphorus pentachloride,
• B) one or more structural units derived from substances of component b), wherein the substances of component b) are selected from one or more compounds of the formula (I) R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w -H (I) wherein R ^{2 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 , particularly preferably 12 to 18 carbon atoms, D is a linear or branched saturated alkylene group having 4 to 20 carbon atoms, a linear or branched mono- or polyunsaturated alkenylene group having 4 to 20 carbon atoms or -CH (aryl) CH ₂ - , preferably -CH (phenyl) CH ₂ -, u, u is a number from 0 to 200, preferably from 2 to 150, particularly preferably from 5 to 100, particularly preferably from 10 to 50, v is a number from 0 to 100, preferably from 0 to 50, particularly preferably from 0 to 20, w is a number from 0 to 100, preferably from 0 to 20, particularly preferably from 0 to 10, and wherein the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of the formula (I) may be arranged block-wise or randomly distributed, and
• C) one or more structural units derived from substances of component c), wherein the substances of component c) are selected from one or more diols of the formula (II) HO- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c -H (II) wherein D has the meaning as in formula (I), a is a number from 0 to 800, preferably from 0 to 250, particularly preferably from 10 to 200 and particularly preferably from 20 to 100, b is a number from 0 to 100, preferably from 0 to 50, c is a number from 0 to 100, preferably from 0 to 20, wherein the sum a + b + c ≥ 1, preferably from 5 to 150, and the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of formula (II) may be arranged blockwise or randomly distributed and the phosphoric acid ester 2 or more derived via a structural unit derived from the compounds of formula (II) bridged P atoms per Contain molecule.

The Phosphoric acid esters according to the invention contain at least 2 phosphorus atoms and can be linear from 4 P atoms or branched structure.

The structural units contained in the phosphoric acid esters according to the invention, which are derived from substances of component b) selected from the compounds of the formula (I), correspond to the formula (I ') R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w - (I ') wherein R ² , D, u, v and w have the meanings given above under formula (I).

The structural units contained in the phosphoric acid esters according to the invention, which are derived from substances of component c) selected from the compounds of the formula (II), correspond to the formula (II ') -O- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c - (II ') wherein a, b, c and D have the meanings given above under formula (II).

essential to the invention is that the phosphoric acid esters of the invention in each case at least one structural unit derived from substances Component a), at least one structural unit according to the formula (I ') and at least a structural unit according to the formula (II ') included.

The Phosphoric acid esters according to the invention do not contain oxygen-oxygen bond -O-O-. The structural units derived from the substances of components a), b) and c) are over only an oxygen atom -O- bonded together.

besitzt, folgende Struktur
R²-O-(CH₂CH₂O)_u(C₃H₆O)_v(DO)_w-P(=O)(-O-)-O-(CH₂CH₂O)_a(C₃H₆O)_b(DO)_c-.For example, a partial structure of a phosphoric ester according to the invention, in each of which a structural unit derived from substances of components b) and c) would be bound to a structural unit derived from the substances of component a), and wherein the structural unit derived from the substances of component a) would have the structure

owns, following structure
R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w -P (= O) (- O -) - O- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c -.

For example, if u = 1, v = w = 0, a = 1, and b = c = 0 in this substructure, the structure would be as follows

A Oxygen-oxygen binding is not in this structural unit contain.

In a preferred embodiment the invention is the number of structural units derived from Substances of component b) per molecule of phosphoric acid ester 2 or more and preferably 3 or more.

In a further preferred embodiment of the invention, R ^{2 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms.

In a further preferred embodiment of the invention are at least 80%, preferably from 90 to 100 %, more preferably from 95 to 100% of the substances of the Component a) theoretically maximum available esterifiable functions in the phosphoric acid esters esterified.

The remaining free valencies on the phosphorus atom, ie the non-esterified of the esterifiable functions, may be acid groups P-OH, but also groups of the form P-O counterion, the counterions being selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ and quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ^{3 are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, and a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms , could be.

Of the Neutralization degree of non-esterified phosphorus valencies (P-OH) in the phosphoric acid esters according to the invention can be between 0 and 100%. In a preferred embodiment the invention is the degree of neutralization of 0-20%. In another preferred embodiment The invention is the degree of neutralization of 20.1-100%.

In a further preferred embodiment v and w are derived in the structural units of the invention the compounds of formula (I) 0.

In a further preferred embodiment of the invention is derived in the structural units from the Compounds of formula (I) from 1 to 150, preferably from 5 to 100, and more preferably from 10 to 50.

In a further preferred embodiment b and c in the structural units of the invention are derived from the compounds of the formula (II) 0.

In a further preferred embodiment of the invention is a derived in the structural units of the Compounds of the formula (II) from 1 to 800, preferably from 10 to 200, and more preferably from 20 to 100.

In a further preferred embodiment of the invention are the one or more structural units derived from the one or more diols of the formula (II) selected from diols from ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, Polyethylene glycol (PEG) with molecular weights from 200 to 35000, preferably PEG 200, PEG 300, PEG 400, PEG 600, PEG 800, PEG 1000, PEG 1500, PEG 2000, PEG 3000, PEG 3350, PEG 4000, PEG 6000, PEG 8000, Propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, Polybutylene glycol, copolymers of ethylene oxide and propylene oxide with molecular weights from 200 to 35,000, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,3-hexanediol, 1,4-hexanediol, 1,5-hexanediol, 1,6-hexanediol and 1,12-dodecanediol.

In a further preferred embodiment of the invention, the one or more structural units derived from the one or more compounds of the formula (I) are structural units in which u is from 1 to 200, preferably from 2 to 150, more preferably from 5 to 100, particularly preferably from 10 to 50, v and w are 0, and the radical R ² -O- is derived from alcohols selected from octanol, decanol, dodecanol, tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl, fatty alcohols with C chain cuts between 8 and 22, preferably C ₁₀ / C ₁₂ fatty alcohol, C ₁₂ / C ₁₄ fatty alcohol, C ₁₂ / C ₁₅ fatty alcohol and C ₁₆ / C ₁₈ fatty alcohol, branched fatty alcohols, preferably Guerbet alcohols and simple unsaturated fatty alcohols, preferably delta-9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol and cis-delta-11-octadecanol.

In a particularly preferred embodiment of the invention, the one or more structural units derived from the one or more compounds of formula (I) are structural units derived from C _15/18 fatty alcohol ethoxylates having 10-50 ethylene oxide units, preferably selected from structural units derived from substances from C _16/18 fatty alcohol ethoxylate with 11 ethylene oxide units, C _16/18 fatty alcohol ethoxylate with 25 ethylene oxide units and C _16/18 fatty alcohol ethoxylate with 50 ethylene oxide units.

In Another particularly preferred embodiment of the invention is the total number in the phosphoric acid esters contained structural units derived from one or the a plurality of compounds of the formula (I), preferably the total number in the phosphoric acid esters contained structural units derived from one or the a plurality of compounds of the formula (I) in which u is a number from 1 to 200, preferably from 2 to 150, more preferably from 5 to 100, in particular preferably from 10 to 50, and v and w are 0, from 4 to 20, preferably from 4 to 10, more preferably from 4 to 6.

In a further preferred embodiment the invention is the total number in the phosphoric acid esters derived ethylene oxide units derived in the structural units of the substances of component b) and the substances of the component c) together per fatty alcohol end group resulting from the compounds of the formula (I) from 30 to 100, preferably from 40 to 80.

worin
M jeweils unabhängig voneinander H⁺ oder ein Gegenion bedeutet und die Gegenionen ausgewählt sind aus Li⁺, Na⁺, K⁺, Mg⁺⁺, Ca⁺⁺, Al⁺⁺⁺, NH₄ ⁺ und quaternären Ammoniumionen [HNR¹R²R³]⁺, wobei R¹, R² und R³ unabhängig voneinander Wasserstoff, eine lineare oder verzweigte Alkylgruppe mit 1 bis 22 Kohlenstoffatomen, eine lineare oder verzweigte, einfach oder mehrfach ungesättigte Alkenylgruppe mit 2 bis 22 Kohlenstoffatomen, eine lineare Mono-Hydroxyalkylgruppe mit 2 bis 10 Kohlenstoffatomen, bevorzugt eine Mono-Hydroxyethyl- oder Mono-Hydroxypropylgruppe, sowie eine lineare oder verzweigte Di-Hydroxyalkylgruppe mit 3 bis 10 Kohlenstoffatomen, sein können,
und vorzugsweise Struktureinheiten der Formel (A1) sind.Further preferred phosphoric acid esters according to the invention are characterized in that the structural units derived from the substances of component a) are selected from structural units of the formulas (A1) to (A3)

wherein
Each M is independently H ⁺ or a counterion and the counterions are selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ and quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ³ unab each hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono -Hydroxypropyl group, as well as a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms,
and are preferably structural units of the formula (A1).

In a further preferred embodiment According to the invention, the phosphoric acid esters consist of structural units derived from the substances of components a), b) and c).

V eine Gruppe der Formel (IIIb) ist

M eine Gruppe der Formel (IIIc) ist

R^a jeweils unabhängig voneinander -OH, -OS oder Reste der Formel (I') R²-O-(CH₂CH₂O)_u(C₃H₆O)_v(DO)_w- (I') sind, worin
S ein Gegenion ist,
R² für eine lineare oder verzweigte, gesättigte Alkylgruppe mit 6 bis 30, vorzugsweise 8 bis 22, besonders bevorzugt 12 bis 18 Kohlenstoffatomen, oder für eine lineare oder verzweigte, ein- oder mehrfach ungesättigte Alkenylgruppe mit 6 bis 30, vorzugsweise 8 bis 22, besonders bevorzugt 12 bis 18 Kohlenstoffatomen, steht,
D für eine lineare oder verzweigte gesättigte Alkylengruppe mit 4 bis 20 Kohlenstoffatomen, für eine lineare oder verzweigte ein- oder mehrfach ungesättigte Alkenylengruppe mit 4 bis 20 Kohlenstoffatomen oder für -CH(Aryl)CH₂-, vorzugsweise -CH(Phenyl)CH₂-, steht,
u für eine Zahl von 0 bis 200, vorzugsweise von 2 bis 150, besonders bevorzugt von 5 bis 100, insbesondere bevorzugt von 10 bis 50, steht,
v für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 50, besonders bevorzugt von 0 bis 20, steht,
w für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 20, besonders bevorzugt von 0 bis 10, steht, und
wobei die Gruppen CH₂CH₂O, C₃H₆O und DO aus den Resten der Formel (I') blockartig oder statistisch verteilt angeordnet sein können,
Q jeweils unabhängig voneinander Reste der Formel (II') -O-(CH₂CH₂O)_a(C₃H₆O)_b(DO)_c- (II')sind, worin
D die Bedeutung wie in Formel (I') hat,
a für eine Zahl von 0 bis 800, vorzugsweise von 0 bis 250, besonders bevorzugt von 10 bis 200 und insbesondere bevorzugt von 20 bis 100, steht,
b für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 50, steht,
c für eine Zahl von 0 bis 100, vorzugsweise von 0 bis 20, steht, und
wobei die Summe a + b + c ≥ 1, vorzugsweise von 5 bis 150, ist und die Gruppen CH₂CH₂O, C₃H₆O und DO aus den Verbindungen der Formel (II') blockartig oder statistisch verteilt angeordnet sein können,
x für eine Zahl von 0 bis 10, bevorzugt 0 bis 5, besonders bevorzugt 0 bis 3, steht und
y für eine Zahl von 0 bis 10, bevorzugt 0 bis 5, besonders bevorzugt 0 bis 3, steht,
mit der Maßgabe, dass die Anzahl der Reste der Formel (I') in den Phosphorsäureestern der Formel (111) größer oder gleich 1, vorzugsweise größer oder gleich 2 und besonders bevorzugt größer oder gleich 3 ist.In a further preferred embodiment of the invention, the phosphoric acid esters according to the invention are selected from compounds of the formula (III) E _{x + 2} V _x M _y (III) wherein
E is a group of the formula (IIIa)

V is a group of formula (IIIb)

M is a group of formula (IIIc)

R ^{a are} each independently of one another -OH, -OS or radicals of the formula (I ') R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w - (I ') are in which
S is a counterion,
R ^{2 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms,
D is a linear or branched saturated alkylene group having 4 to 20 carbon atoms, a linear or branched mono- or polyunsaturated alkenylene group having 4 to 20 carbon atoms or -CH (aryl) CH ₂ -, preferably -CH (phenyl) CH ₂ - , stands,
u is a number from 0 to 200, preferably from 2 to 150, particularly preferably from 5 to 100, particularly preferably from 10 to 50,
v is a number from 0 to 100, preferably from 0 to 50, particularly preferably from 0 to 20,
w is a number from 0 to 100, preferably from 0 to 20, particularly preferably from 0 to 10, and
where the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the radicals of the formula (I ') can be arranged block-wise or randomly distributed,
Each independently of one another radicals of the formula (II ') -O- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c - (II ') are in which
D has the meaning as in formula (I '),
a is a number from 0 to 800, preferably from 0 to 250, particularly preferably from 10 to 200 and in particular preferably from 20 to 100,
b is a number from 0 to 100, preferably from 0 to 50,
c is a number from 0 to 100, preferably from 0 to 20, and
wherein the sum of a + b + c ≥ 1, preferably from 5 to 150, and the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of formula (II ') may be arranged blockwise or randomly distributed .
x is a number from 0 to 10, preferably 0 to 5, particularly preferably 0 to 3, and
y is a number from 0 to 10, preferably 0 to 5, particularly preferably 0 to 3,
with the proviso that the number of radicals of the formula (I ') in the phosphoric acid esters of the formula (III) is greater than or equal to 1, preferably greater than or equal to 2 and particularly preferably greater than or equal to 3.

In the phosphoric acid esters of the formula (III), there are no structural units -Q-Q-, i. whenever two structural units selected from the formulas (IIIa), (IIIb) and (IIIc) is located between the two structural units only one group Q.

The simplest structure of the formula (III) would be a structure of the formula E ₂ V ₀ M ₀ for x = 0 and y = ₀ . The formula E ₂ V ₀ M ₀ can also be represented by the following structural formula of two structural units of the formula (IIIa)

Also From this structural formula one recognizes that between the two structural units of the formula (IIIa) only a single group Q is bound.

in the The following are preferred embodiments for the organophosphate of the formula (III).

Preferably, R ² in the radicals of the formula (I ') is a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms.

Farther preferred phosphoric acid esters of the formula (III) are those in which at least 80%, preferably from 90 to 100%, more preferably from 95 to 100%, directly esterified to the phosphorus atoms P esterified esterified functions are.

Of the Neutralization degree of non-esterified phosphorus valences in the Phosphorsäureestern of formula (III) may be between 0 and 100%. In a preferred embodiment the invention is the degree of neutralization of 0-20%. In another preferred embodiment The invention is the degree of neutralization of 20.1-100%.

Preferred counterions S in the phosphoric acid esters of the formula (III) are selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ and quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ^{3 are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, as well as a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms, may be.

Farther preferred phosphoric acid esters of the formula (III) are those wherein v and w in the radicals of the formula (I ') are 0.

Farther preferred phosphoric acid esters of the formula (III) are those in which u in the radicals of the formula (I ') is from 1 to 150, preferably from 5 to 100 and more preferably from 10 to 50 is.

Farther preferred phosphoric acid esters of the formula (III) are those wherein b and c in the radicals of the formula (II ') are 0.

Farther preferred phosphoric acid esters of the formula (III) are those in which a in the radicals of the formula (II ') is from 1 to 800, preferably from 10 to 200 and more preferably from 20 to 100 is.

Farther preferred phosphoric acid esters of the formula (III) are those wherein the one or more radicals of the formula (II ') are derived from diols selected from ethylene glycol, diethylene glycol, Triethylene glycol, tetraethylene glycol, polyethylene glycol (PEG) with Molecular weights from 200 to 35,000, preferably PEG 200, PEG 300, PEG 400, PEG 600, PEG 800, PEG 1000, PEG 1500, PEG 2000, PEG 3000, PEG 3350, PEG 4000, PEG 6000, PEG 8000, propylene glycol, dipropylene glycol, Tripropylene glycol, polypropylene glycol, polybutylene glycol, copolymers of ethylene oxide and propylene oxide having molecular weights of 200 bis 35000, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,3-hexanediol, 1,4-hexanediol, 1,5-hexanediol, 1,6-hexanediol and 1,12-dodecanediol.

Further preferred phosphoric acid esters of the formula (III) are those in which u in the radicals of the formula (I ') is from 1 to 200, preferably from 2 to 150, particularly preferably from 5 to 100 and particularly preferably from 10 to 50, v and w in the radicals of the formula (I ') are 0 and the groups R ² -O- in the radicals of the formula (I') are derived from alcohols selected from octanol, decanol, dodecanol, tetradecanol, hexadecanol, octadecanol, eicosanol, behenyl alcohol , Fatty alcohols with C chain cuts between 8 and 22, preferably C ₁₀ / C ₁₂ fatty alcohol, C ₁₂ / C ₁₄ fatty alcohol, C ₁₂ / C ₁₅ fatty alcohol, C ₁₆ / C ₁₈ fatty alcohol, branched fatty alcohols, preferably Guerbet alcohols, monounsaturated fatty alcohols, preferably delta-9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol and cis-delta-11-octadecanol.

Particularly preferred phosphoric acid esters of the formula (III) according to the invention are those in which the radicals of the formula (I ') are derived from C _16/18 fatty alcohol ethoxylates having 10-50 ethylene oxide units, preferably from substances selected from C _16/18 fatty alcohol ethoxylate 11 ethylene oxide units, C _16/18 fatty alcohol ethoxylate with 25 ethylene oxide units and C _16/18 fatty alcohol ethoxylate with 50 ethylene oxide units.

Farther particularly preferred phosphoric acid esters of the formula (III) are those in which the total number of those contained therein Radicals of the formula (I '), preferably the total number of radicals of the formula contained therein (I '), where u of 1 to 200, preferably from 2 to 150, more preferably from 5 to 100, and more preferably from 10 to 50, and v and w 0 are from 4 to 20, preferably from 4 to 10, particularly preferred from 4 to 6, is.

Farther preferred phosphoric acid esters of the formula (III) are those in which the total number of structural units in the of the formulas (I ') and (II ') contained Ethylene oxide units together per radical of formula (I ') from 30 to 100, preferably from 40 to 80, is.

The present invention also provides mixtures comprising one or more phosphoric acid esters according to the invention. In a preferred embodiment of the invention, these mixtures may also be phosphoric acid esters having only one phosphoric acid atom per molecule, in particular those of the formula [R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w -] ₃ P = O, wherein R ² , u, v, w and D have the meanings mentioned above among the compounds of the formula (I). Among these mixtures, in turn, those are preferred which consist of said phosphoric acid esters. The proportion of the inventive phosphoric acid esters in the mixtures according to the invention is preferably greater than 50% by weight, more preferably from 70 to 100% by weight and particularly preferably from 80 to 100% by weight. In another preferred embodiment of the invention, the mixtures according to the invention consist of the phosphoric acid esters according to the invention.

The Representation of the phosphoric acid esters according to the invention takes place by reaction of phosphoric acid or its derivatives with Alcohol, preferably fatty alcohol ethoxylate, and diol at temperatures from 150 to 250 ° C, preferably from 180 to 240 ° C and more preferably from 200 to 230 ° C.

suitable phosphoric acid derivatives are polyphosphoric acid, Tetraphosphorodecoxide, phosphorus oxychloride and phosphorus pentachloride.

preferred Recktand is orthophosphoric acid.

The Esterification is preferably carried out to the extent that substantially neutral Phosphoric acid esters according to the invention available. Preferably, a degree of conversion> 80%, i. more than 80% of all esterifiable Functions of phosphoric acid or the phosphoric acid derivatives are esterified. Particularly preferred is a degree of conversion> 90%, in particular preferably> 95%.

The remaining free valences on the phosphorus atom may be acid groups, but also counterions, selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ , quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , where R ¹ , R ² and R ^{3 are} independently each other is hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono- Hydroxypropyl group, as well as a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms.

Of the Neutralization degree of unsubstituted phosphorus valencies (P-OH) can be between 0 and 100%.

• a) 3-10 Mol, vorzugsweise 4-8 Mol, eines C₁₂-C₂₂-Fettalkoholethoxylats, vorzugsweise eines C_16/18-Fettalkoholethoxylats, mit 10-50 Ethylenoxid-Einheiten,
• b) 2 Mol Polyethylenglykol mit einem mittleren Molekulargewicht von 1500-8000, und
• c) 2-5 Mol, vorzugsweise 2,5-4 Mol, Orthophosphorsäure.

Particularly preferred phosphoric acid esters according to the invention are obtainable from the reaction of

• a) 3-10 moles, preferably 4-8 moles, of a C ₁₂ -C ₂₂ fatty alcohol ethoxylate, preferably a C _16/18 fatty alcohol ethoxylate, with 10-50 ethylene oxide units,
• b) 2 moles of polyethylene glycol having an average molecular weight of 1500-8000, and
• c) 2-5 mol, preferably 2.5-4 mol, orthophosphoric acid.

• a) 5 Mol eines C₁₂-C₂₂-Fettalkoholethoxylats, vorzugsweise eines C_16/18-Fettalkoholethoxylats, mit 10-50 Ethylenoxid-Einheiten, vorzugsweise 25 Ethylenoxid-Einheiten,
• b) 2 Mol Polyethylenglykol mit einem mittleren Molekulargewicht von 1500-8000, vorzugsweise mit einem mittleren Molekulargewicht von 4000 und
• c) 3 Mol Orthophosphorsäure.

Particularly preferred phosphoric acid esters according to the invention are obtainable from the reaction of

• a) 5 moles of a C ₁₂ -C ₂₂ fatty alcohol ethoxylate, preferably a C _16/18 fatty alcohol ethoxylate, with 10-50 ethylene oxide units, preferably 25 ethylene oxide units,
• b) 2 moles of polyethylene glycol having an average molecular weight of 1500-8000, preferably having an average molecular weight of 4000 and
• c) 3 moles of orthophosphoric acid.

• a) 5 Mol eines C_16/18-Fettalkoholethoxylats mit 25 Ethylenoxid-Einheiten,
• b) 2 Mol Polyethylenglykol mit einem mittleren Molekulargewicht von 4000 und
• c) 3 Mol Orthophosphorsäure.

Extremely preferred phosphoric acid esters according to the invention are obtainable from the reaction of

• a) 5 moles of a C _16/18 fatty alcohol ethoxylate with 25 ethylene oxide units,
• b) 2 moles of polyethylene glycol having an average molecular weight of 4000 and
• c) 3 moles of orthophosphoric acid.

The phosphoric acid ethers according to the invention have excellent thickening power, both for compositions on watery or more watery-alcoholic than also for Compositions on aqueous-surfactant Base and tolerate organic solvents such as alcohols.

The Phosphoric acid esters according to the invention are also advantageously used as thickener, bodying agent, Emulsifier, sensor additive, solubilizer, dispersant, lubricant, Adhesive and stabilizer suitable.

One Another object of the invention therefore relates to the use one or more of the phosphoric acid esters according to the invention as thickener, bodying agent, emulsifier, sensory additive, solubilizer, dispersing agent, Lubricant, adhesive and stabilizer.

Of Also suitable are the phosphoric acid esters according to the invention also advantageously for the production of cosmetic, pharmaceutical and dermatological compositions.

The Phosphoric acid esters according to the invention are also beneficial for the thickening of cosmetic, containing pharmaceutical and dermatological compositions one or more surfactants suitable. These are preferably around shampoos.

One Another object of the invention is therefore also the use one or more inventive phosphoric acid esters for thickening of cosmetic, pharmaceutical and dermatological Compositions containing one or more surfactants, preferably of shampoos.

Especially in deodorant or antiperspirant formulations containing aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts the phosphoric acid esters according to the invention contained therein after application of the formulations on the skin, the formation of white residues the following dressed clothes.

Another object of the present invention is therefore the use of one or more inventive phosphoric acid esters in deodorant or antiperspirant formulations, in particular in Deodorant or antiperspirant formulations containing aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts, to reduce the formation of white residue on clothing after application of the deodorant or antiperspirant formulations to the skin.

One Another object of the invention are cosmetic, pharmaceutical and dermatological compositions containing one or more the phosphoric acid esters of the invention.

The Phosphoric acid esters according to the invention have diverse applications and are suitable for the use in aqueous, aqueous-alcoholic and aqueous surfactant compositions, Emulsions, suspensions, dispersions, powders and sprays.

preferred Compositions of the invention are in the form of aqueous, aqueous-alcoholic or aqueous-surfactant Compositions, emulsions, suspensions, dispersions, powders or Sprays in front.

The Phosphoric acid esters according to the invention can as a thickener for Agent on watery or aqueous-alcoholic Base, for example hair gels, moisturizing gels, antiperspirant gels, Bleaching gels, conditioners and disinfecting gels used become. Furthermore, the phosphoric acid esters according to the invention are suitable as a stabilizer, dispersant and bodying agent for aqueous-surfactant Preparations, for example shampoos, shower baths, shower gels and bubble baths and to improve skin mildness and skin compatibility.

The thickening effect of the phosphoric acid esters according to the invention in aqueous-surfactant compositions is due to the association of the hydrophobic end groups with the surfactant micelles caused by the choice of Ethoxylatendgruppen the Phosphoric acid esters according to the invention and controlled by the choice of surfactants.

The suspending or dispersing and stabilizing action of Phosphoric acid esters according to the invention in aqueous-surfactant Compositions become due to the association of the hydrophobic end groups and in aqueous-surfactant compositions insoluble liquid Components, such as oils and Silicone oils, or the insoluble one Solid components, for example pigments and active substances such as zinc pyrethiones, conditionally.

The Phosphoric acid esters according to the invention are also suitable as thickeners and dispersants, as emulsifiers, Suspending agent with thickening effect and bodying agent for emulsions and suspensions, such as conditioners, as well as lubricants, adhesives, Thickeners, dispersants and emulsifiers decorative, solids-containing Preparations. It can also mixtures of the phosphoric acid esters according to the invention be used. The emulsifying, stabilizing and / or restorative Effect of the phosphoric acid esters according to the invention in emulsions is characterized by an association of the hydrophobic end groups with each other, and by an interaction of the hydrophobic end groups with the hydrophobic oil components caused or amplified.

In a preferred embodiment The invention relates to the cosmetic, pharmaceutical according to the invention or intestinal compositions as emulsions.

at the emulsions can be both water-in-oil emulsions and oil-in-water emulsions, Microemulsions and multiple emulsions act.

The Preparation of the emulsions can be carried out in known manner, i. for example by hot, Hot / cold or PIT emulsification done.

Of the non-aqueous Proportion of the emulsions, which largely consists of the emulsifier, the Thickener and the oil body is usually at 5 to 95 wt .-%, preferably at 15 to 75 wt .-%. It follows, the emulsions contain 5 to 95% by weight, preferably 25 to 85% by weight May contain water, depending on whether lotions with a comparatively low, or creams and High viscosity ointments to be produced.

In a further preferred embodiment The invention relates to the phosphoric acid esters according to the invention in rinse-off products, preferably shampoos, shower baths, shower gels and bubble baths, used.

In a further preferred embodiment The invention relates to the phosphoric acid esters according to the invention in leave-on products, preferably skincare products such as day creams, Night creams, moisturizing lotions and gels, aqueous gels, such as Facial toners, Nursing creams, Nourishing creams, Body lotions, ointments, sunscreens, lip balms, antiperspirants and deodorants.

Of Furthermore, they are also suitable for surfactant-free, aqueous Compositions and emulsions as well as for hair treatments, hair conditioners and Hair gels, but also for Permanent wave, hair dye, as well as for decorative Cosmetics, such as make-ups, eye-shadows, lipsticks, mascara and the same.

Especially It is advantageous that the thickening power even in strongly acidic medium and is expressed in electrolyte-containing compositions.

The Phosphoric acid esters according to the invention are therefore particularly suitable for thickening and stabilization of acidic cosmetic compositions. This can e.g. be cosmetic compositions containing hydroxy acids, such as lactic acid, glycolic acid, salicylic acid, citric acid or polyglycol contained in free or partial neutralization. Furthermore, formulations containing vitamin C or vitamin C derivatives, dihydroxyacetone or Skin whitening acts like arbutin or glycyrrhetinic acid and their Salts are stabilized.

In a further preferred embodiment of the invention, the compositions of the invention have a pH of from 2 to 10, preferably from 2 to 6, more preferably from 2.5 to 5, and more preferably from 3 to 4.5.

The Phosphoric acid esters according to the invention are also very suitable as thickener electrolyte-containing Compositions.

The electrolyte used are inorganic salts, preferably ammonium or metal salts, particularly preferably halides, for example CaCl ₂ , MgCl ₂ , LiCl, KCl, NaCl, carbonates, hydrogencarbonates, phosphates, sulfates, nitrates, particularly preferably sodium chloride, and / or organic Salts, preferably ammonium or metal salts, particularly preferably glycolic acid, lactic acid, citric acid, tartaric acid, mandelic acid, salicylic acid, ascorbic acid, pyruvic acid, fumaric acid, retinoic acid, sulfonic acids, benzoic acid, kojic acid, fruit acid, malic acid, gluconic acid or galacturonic acid.

When Electrolyte can the compositions of the invention also mixtures of different salts.

In a further preferred embodiment invention, the compositions of the invention contain a or more electrolytes.

For this counting also watery Antiperspirant formulations containing aluminum salts, preferably aluminum chlorohydrate or aluminum-zirconium complex salts.

Of the Content of the one or more electrolytes in the compositions according to the invention, is, based on the total composition of the invention, preferably from 0.1 to 20.0% by weight, more preferably from 0.2 to 10.0% by weight and more preferably from 0.5 to 5.0% by weight.

Very It is advantageous that the phosphoric acid esters according to the invention Compositions containing oxidizing agents, preferably hydrogen peroxide, contain, for example, hair dyes, both thicken and stabilize.

In a further preferred embodiment invention, the compositions of the invention contain hydrogen peroxide or hydrogen peroxide-releasing substances. These compositions are preferably in the form of gels.

When Hydrogen peroxide-releasing substances are preferably present in Considering inorganic peracids, preferably peroxosulphuric acid, peroxodisulfuric, Peroxocarbonates, as well as organic peracids, preferably peracetic acid.

In a further preferred embodiment In the invention, the compositions of the invention are acidic Hydrogen peroxide bleaching gels or creams.

The Compositions of the invention contained, based on the finished cosmetic, pharmaceutical or dermatological compositions, preferably 0.01 to 10.0 Wt .-%, particularly preferably 0.1 to 6.0 wt .-% and in particular preferably 0.5 to 3.0 wt .-% of the phosphoric acid esters according to the invention.

The Compositions of the invention can anionic, cationic, nonionic, ampholytic surfactants and / or Betaine surfactants included. The total amount of in the agents (e.g. in the case of rinse-off products) used surfactants, based on the finished compositions according to the invention, preferably 1 to 70 wt .-%, particularly preferably 5 to 40 wt .-% and in particular preferably 10 to 35 wt .-%.

Preferred anionic surfactants are (C ₁₀ -C ₂₂ ) -alkyl and alkylene carboxylates, alkyl ether carboxylates, fatty alcohol sulfates, fatty alcohol ether sulfates, alkyl amide sulfates and sulfonates, fatty acid alkylamide polyglycol ether sulfates, alkanesulfonates and hydroxyalkanesulfonates, olefin sulfonates, acyl esters of isethionates, α-sulfofatty acid esters, alkylbenzenesulfonates, alkylphenol glycol ether sulfonates , Sulfosuccinates, sulfosuccinic monoesters and diesters, fatty alcohol phosphates, fatty alcohol ether phosphates, protein-fatty acid condensation products, alkyl monoglyceride sulfates and sulfonates, alkyl glyceride ether sulfonates, fatty acid methyltaurides, fatty acid sarcosinates, sulforicinoleates, acylglutamates and acylglycinates. These compounds and their mixtures are used in the form of their water-soluble or water-dispersible salts, for example the sodium, potassium, magnesium, ammonium, mono-, di- and triethanolammonium and analogous alkylammonium salts.

The Amount of anionic surfactants in the compositions of the invention is preferably from 2 to 30 wt .-%, particularly preferably from 5 to 25 Wt .-% and particularly preferably from 12 to 22 wt .-%, based on the finished compositions.

Preferred cationic surfactants are quaternary ammonium salts such as di (C ₈ -C ₂₂ ) alkyl dimethyl ammonium chloride or bromide, preferably di (C ₈ -C ₂₂ ) alkyl dimethyl ammonium chloride or bromide; (C ₈ -C ₂₂ ) alkyldimethyl-dimethylammonium chloride or bromide; (C ₈ -C ₂₂ ) alkyltrimethylammonium chloride or bromide, preferably cetyltrimethylammonium chloride or bromide and (C ₈ -C ₂₂ ) -alkyltrimethylammonium chloride or bromide; (C ₁₀ -C ₂₄ ) alkyldimethylbenzylammonium chloride or bromide, preferably (C ₁₂ -C ₁₈ ) alkyldimethylbenzylammonium chloride, (C ₈ -C ₂₂ ) alkyldimethylhydroxyethylammonium chloride, phosphate, sulfate, lactate , (C ₈ -C ₂₂ ) -alkylamidopropyltrimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ -C ₂₂ -alkanoyl-oxyethyl) -dimethylammonium chloride, methosulfate, N, N-bis (2-C ₈ -C ₂₂ alkanoyl-oxyethyl) hydroxyethyl-methyl-ammonium chloride, methosulfate.

The Amount of cationic surfactants in the compositions of the invention is preferably 0.1 to 10 wt .-%, particularly preferably 0.5 to 7 wt .-% and particularly preferably 1 to 5 wt .-%, based on the finished Compositions.

Preferred nonionic surfactants are fatty alcohol ethoxylates (alkylpolyethylene glycols); Alkylphenolpolyethylenglykole; Fatty amine ethoxylates (alkylaminopolyethylene glycols); Fatty acid ethoxylates (acyl polyethylene glycols); Polypropylenglykolethoxylate (Pluronics ^®); Fatty acid alkanolamides, (fatty acid amide polyethylene glycols); Saccharoseester; Sorbitol esters and sorbitan esters and their polyglycol ethers, and C ₈ -C ₂₂ -Alkylpolyglucoside.

The Amount of nonionic surfactants in the compositions of the invention (e.g., in the case of rinse-off products) is preferably in the range from 1 to 20 wt .-%, particularly preferably from 2 to 10 wt .-% and particularly preferably from 3 to 7 wt .-%, based on the finished Compositions.

Furthermore, the compositions of the invention may contain amphoteric surfactants. These can be described as derivatives of long-chain secondary or tertiary amines which are eliminated via an alkyl group having 8 to 18 carbon atoms and in which a further group is substituted by an anionic group which mediates water solubility, for example with a carboxyl, sulfate - or sulfonate group. Preferred amphoteric surfactants are N- (C ₁₂ -C ₁₈ ) -alkyl-β-aminopropionates and N- (C ₁₂ -C ₁₈ ) -alkyl-β-iminodipropionates as the alkali metal and mono-, di- and trialkylammonium salts; Suitable further surfactants are also amine oxides. These are oxides of tertiary amines with a long-chain group of 8 to 18 carbon atoms and two mostly short-chain alkyl groups with 1 to 4 carbon atoms. Preference is given here, for example, to the C ₁₀ - to C ₁₈ -alkyldimethylamine oxides, fatty acid-amidoalkyl-dimethylamine oxide.

Another preferred group of surfactants are betaine surfactants, also called zwitterionic surfactants. These contain in the same molecule a cationic group, in particular an ammonium group and an anionic group, which may be a carboxylate group, sulfate group or sulfonate group. Suitable betaines are preferably alkylbetaines such as coco-betaine or fatty acid alkylamidopropylbetaines, for example cocoacylamidopropyldimethylbetaine or the C ₁₂ - to C ₁₈ -dimethylaminohexanoates or the C ₁₀ - to C ₁₈ -acylamidopropanedimethylbetaines.

The Amount of amphoteric surfactants and / or betaine surfactants in the compositions of the invention is preferably from 0.5 to 20 wt .-% and particularly preferably from 1 to 10 wt .-%, based on the finished compositions.

preferred Surfactants are lauryl sulfate, laureth sulfate, cocoamidopropyl betaine, Alkylbetaines such as coco-betaine, sodium cocoylglutamate and lauroamphoacetate.

In a further preferred embodiment of the invention additionally contain the compositions according to the invention as foam-enhancing Medium cosurfactants from the group of alkylbetaines, alkylamidobetaines, Aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines, Amine oxides, fatty acid alkanolamides and polyhydroxyamides.

In a preferred embodiment The invention includes the cosmetic, pharmaceutical and dermatological Compositions, in addition to the one or more phosphoric acid esters according to the invention, one or more surfactants.

The Compositions of the invention can as further auxiliaries and additives oil body, silicone oils, waxes, Emulsifiers, co-emulsifiers, solubilizers, stabilizers, cationic Polymers, film formers, thickeners, gelling agents, superfatting agents, Moisturizing agent, antimicrobial agents, biogenic agents, astringents, deodorants, sunscreens, antioxidants, humectants, Solvents, Dyes, Perfumes, pearlescing agents, opacifiers and / or water-soluble Contain silicones.

The oil body can advantageously selected are selected from the groups of triglycerides, natural and synthetic fats, preferably Esters of fatty acids with lower C number alcohols, e.g. with isopropanol, propylene glycol or glycerol, or esters of fatty alcohols lower with alkanoic acids C number or with fatty acids or from the group of alkyl benzoates, as well as natural or synthetic Hydrocarbon oils.

Suitable triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated, C ₈ -C ₃₀ -fatty acids, in particular vegetable oils, such as sunflower, maize, soybean, rice, jojoba, babussu, pumpkin, Grapeseed, sesame, walnut, apricot, orange, wheat germ, peach kernel, macadamia, avocado, sweet almond, meadowfoam, castor oil, olive oil, peanut oil, rapeseed oil and coconut oil, as well as synthetic triglyceride oils, eg the commercial product myritol ^® 318. Even hardened triglycerides are inventively preferred. It is also possible to use oils of animal origin, for example beef tallow, perhydrosqualene, lanolin.

Another class of preferred oil bodies according to the invention, the benzoic acid esters of linear or branched C _8-22 alkanols, for example the commercial products Finsolv ^® SB (isostearyl benzoate), Finsolv ^® TN _(C12-C15 alkyl benzoate) and Finsolv EB ^® (ethylhexyl) ,

Another class of oil bodies preferred according to the invention are the dialkyl ethers having a total of 12 to 36 carbon atoms, in particular having 12 to 24 carbon atoms, such as di-n-octyl ether (Cetiol ^® OE), di-n-nonyl ether, di-n-decyl ether, di n-undecyl ether, di-n-dodecyl ether, n-hexyl n-octyl ether, n-octyl n-decyl ether, n-decyl n-undecyl ether, n-undecyl n-dodecyl ether and n-hexyl n-undecyl ether , Di-3-ethyldecyl ether, tert-butyl-n-octyl ether, iso-pentyl-n-octyl ether and 2-methyl-pentyl-n-octyl ether and di-tert-butyl ether and di-iso-pentyl ether.

As well Branched saturated or unsaturated fatty alcohols are suitable with 6-30 carbon atoms, e.g. Isostearyl alcohol, as well as Guerbet alcohols.

Another class of oil bodies preferred according to the invention are hydroxycarboxylic acid alkyl esters. Preferred hydroxycarboxylic acid alkyl esters are full esters of glycolic acid, lactic acid, malic acid, tartaric acid or citric acid. Other basically suitable esters of hydroxycarboxylic acids are esters of β-hydroxypropionic acid, tartronic acid, D-gluconic acid, sugar acid, mucic acid or glucuronic acid. As the alcohol component of these esters are primary, linear or branched aliphatic alcohols having 8 to 22 carbon atoms. The esters of C ₁₂ -C ₁₅ fatty alcohols are particularly preferred. Esters of this type are commercially available, eg under the trade name Cosmacol® ^® EniChem, Augusta Industriale.

Another class of the present invention preferred oily substances are dicarboxylic acid esters of linear or branched C ₂ -C ₁₀ alkanols, such as di-n-butyl adipate (Cetiol ^® B), di- (2-ethylhexyl) adipate and di- (2-ethylhexyl) succinate and diol esters such as ethylene glycol dioleate, ethylene glycol di-isotridecanoate, propylene glycol di- (2-ethylhexanoate), propylene glycol di-isostearate, propylene glycol di-pelargonate, butanediol di-isostearate and neopentyl glycol dicaprylate, and di-isotridecyl acelate.

Likewise preferred oil bodies are symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, glycerol carbonate or dicaprylyl carbonate (Cetiol ^® CC).

Another class of oil bodies preferred according to the invention are the esters of dimers of unsaturated C ₁₂ -C ₂₂ -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C ₂ -C ₁₈ -alkanols or with polyfunctional linear or branched C ₂ -C ₅ -alkanols ,

Another class of oil bodies preferred according to the invention are hydrocarbon oils, for example those with linear or branched, saturated or unsaturated C ₇ -C ₄₀ -carbon chains, for example Vaseline, dodecane, isododecane, cholesterol, lanolin, synthetic hydrocarbons such as polyolefins, in particular polyisobutene, hydrogenated polyisobutene , polydecane, and hexadecane, isohexadecane, paraffin oils, isoparaffin oils, such as the commercial products of the Permethyl ^® series, squalane, squalene, and alicyclic hydrocarbons, for example the commercial product 1,3-di- (2-ethyl-hexyl) (-cyclohexane Cetiol ^® S), ozokerite, and ceresin.

Dimethylpolysiloxanes and cyclomethicones, polydialkylsiloxanes R ₃ SiO (R ₂ SiO) _x SiR ₃ , where R is methyl or ethyl, particularly preferably methyl, and x is a number from 2 to 500, are preferably available for silicone oils or waxes , for example, under the trade name Vicasil (General Electric Company), DOW CORNING 200, DOW CORNING 225, DOW CORNING 200 (Dow Corning Corporation), available dimethicone, and under SilCare® ^® Silicone 41M65, SilCare® ^® Silicone 41M70, SilCare® ^® Silicone 41M80 (Clariant GmbH) available Dimethicone, Stearyldimethylpolysiloxan, C ₂₀ -C ₂₄ alkyl dimethylpolysiloxane, C ₂₄ -C ₂₈ alkyl dimethylpolysiloxane, but also the silicones available under SilCare ^® Silicone 41M40, SilCare ^® Silicone 41M50 (Clariant GmbH), continue Trimethylsiloxysilicate [(CH ₂ ) ₃ SiO) _1/2 ] _x [SiO ₂ ] _y , where x is a number from 1 to 500 and y is a number from 1 to 500, dimethiconols R ₃ SiO [R ₂ SiO] _x SiR ₂ OH u and HOR ₂ SiO [R ₂ SiO] _x SiR ₂ OH, where R is methyl or ethyl and x is a number up to 500, polyalkylaryl siloxanes, for example, those under the trade designations SF 1075 METHYLPHENYL FLUID (General Electric Company) and 556 COSMETIC GRADE PHENYL TRIMETHICONE FLUID (Dow Corning Corporation) available polymethylphenylsiloxanes, polydiarylsiloxanes, silicone resins, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine and / or alkyl-modified silicone compounds, and polyethersiloxane copolymers.

The Compositions of the invention can Waxes, for example paraffin waxes, microwaxes and ozokerites, Beeswax and its sub-fractions and beeswax derivatives, Waxes from the group of homopolymeric polyethylenes or copolymers the α-olefins, as well as natural Waxes such as rice wax, candellila wax, carnauba wax, Japan wax or shellac wax.

When Emulsifiers, co-emulsifiers and solubilizers can be nonionic, anionic, cationic or amphoteric surface-active compounds used become.

Suitable nonionic surface-active compounds are preferably addition products of from 0 to 30 mol of ethylene oxide and / or from 0 to 5 mol of propylene oxide to linear fatty alcohols having from 8 to 22 carbon atoms, to fatty acids having from 12 to 22 carbon atoms, to alkylphenols having from 8 to 15 C atoms in the alkyl group and on sorbitol or sorbitol esters; (C ₁₂ -C ₁₈ ) fatty acid mono- and diesters of addition products of 0 to 30 moles of ethylene oxide with glycerol; Glycerol mono- and diesters and sorbitan mono- and diesters of saturated and unsaturated fatty acids having 6 to 22 carbon atoms and optionally their ethylene oxide addition products; Addition products of 15 to 60 moles of ethylene oxide with castor oil and / or hydrogenated castor oil; Polyol and especially polyglycerol esters, such as polyglycerol polyricinoleate and polyglycerol poly-12-hydroxy stearate. Also preferably suitable are ethoxylated fatty amines, fatty acid amides, fatty acid alkanolamides and mixtures of compounds of several of these classes of substances.

When Ionogenic co-emulsifiers are useful e.g. anionic emulsifiers, like mono-, di- or tri-organophosphate, Soaps (e.g., sodium stearate), fatty alcohol sulfates, but also cationic ones Emulsifiers such as mono-, di- and tri-alkyl quats and their polymers Derivatives.

At amphoteric emulsifiers are preferably available alkylaminoalkylcarboxylic acids, betaines, Sulfobetaines and imidazoline derivatives.

Especially Fatty alcohol ethoxylates selected from are preferably used the group of ethoxylated stearyl alcohols, isostearyl alcohols, Cetyl alcohols, isocetyl alcohols, oleyl alcohols, lauryl alcohols, isolauryl alcohols, Cetylstearyl alcohols, in particular polyethylene glycol (13) stearyl ether, Polyethylene glycol (14) stearyl ether, polyethylene glycol (15) stearyl ether, Polyethylene glycol (16) stearyl ether, polyethylene glycol (17) stearyl ether, Polyethylene glycol (18) stearyl ether, polyethylene glycol (19) stearyl ether, Polyethylene glycol (20) stearyl ether, polyethylene glycol (12) isostearyl ether, Polyethylene glycol (13) isostearyl ether, polyethylene glycol (14) isostearyl ether, Polyethylene glycol (15) isostearyl ether, polyethylene glycol (16) isostearyl ether, Polyethylene glycol (17) isostearyl ether, polyethylene glycol (18) isostearyl ether, Polyethylene glycol (19) isostearyl ether, polyethylene glycol (20) isostearyl ether, Polyethylene glycol (13) cetyl ether, polyethylene glycol (14) cetyl ether, Polyethylene glycol (15) cetyl ether, polyethylene glycol (16) cetyl ether, Polyethylene glycol (17) cetyl ether, polyethylene glycol (18) cetyl ether, Polyethylene glycol (19) cetyl ether, polyethylene glycol (20) cetyl ether, Polyethylene glycol (13) isocetyl ether, polyethylene glycol (14) isocetyl ether, Polyethylene glycol (15) isocetyl ether, polyethylene glycol (16) isocetyl ether, Polyethylene glycol (17) isocetyl ether, polyethylene glycol (18) isocetyl ether, Polyethylene glycol (19) isocetyl ether, polyethylene glycol (20) isocetyl ether, Polyethylene glycol (12) oleyl ether, polyethylene glycol (13) oleyl ether, polyethylene glycol (14) oleyl ether, Polyethylene glycol (15) oleyl ether, polyethylene glycol (12) lauryl ether, Polyethylene glycol (12) isolauryl ether, polyethylene glycol (13) cetyl stearyl ether, Polyethylene glycol (14) cetyl stearyl ether, polyethylene glycol (15) cetyl stearyl ether, Polyethylene glycol (16) cetyl stearyl ether, polyethylene glycol (17) cetyl stearyl ether, Polyethylene glycol (18) cetyl stearyl ether, polyethylene glycol (19) cetyl stearyl ether.

As well preferred are fatty acid ethoxylates, chosen from the group of ethoxylated stearates, isostearates and oleates, in particular polyethylene glycol (20) stearate, polyethylene glycol (21) stearate, Polyethylene glycol (22) stearate, polyethylene glycol (23) stearate, polyethylene glycol (24) stearate, Polyethylene glycol (25) stearate, polyethylene glycol (12) isostearate, polyethylene glycol (13) isostearate, Polyethylene glycol (14) isostearate, polyethylene glycol (15) isostearate, Polyethylene glycol (16) isostearate, polyethylene glycol (17) isostearate, Polyethylene glycol (18) isostearate, polyethylene glycol (19) isostearate, Polyethylene glycol (20) isostearate, polyethylene glycol (21) isostearate, Polyethylene glycol (22) isostearate, polyethylene glycol (23) isostearate, Polyethylene glycol (24) isostearate, polyethylene glycol (25) isostearate, Polyethylene glycol (12) oleate, polyethylene glycol (13) oleate, polyethylene glycol (14) oleate, Polyethylene glycol (15) oleate, polyethylene glycol (16) oleate, polyethylene glycol (17) oleate, Polyethylene glycol (18) oleate, polyethylene glycol (19) oleate, polyethylene glycol (20) oleate.

When ethoxylated alkyl ether carboxylic acid or its salts may advantageously be the sodium laureth-11-carboxylate be used.

When ethoxylated triglycerides can Advantageous Polyethylene Glycol (60) Evening Primrose Glycerides used become.

Farther it is advantageous to use the polyethylene glycol glycerin fatty acid esters from the group polyethylene glycol (20) glyceryl laurate, polyethylene glycol (6) glyceryl caprate / caprinate, Polyethylene glycol (20) glyceryl oleate, polyethylene glycol (20) glyceryl isostearate and polyethylene glycol (18) glyceryl oleate / cocoate.

Under The sorbitan esters are especially suitable for polyethylene glycol (20) sorbitan monolaurate, Polyethylene glycol (20) sorbitan monostearate, polyethylene glycol (20) sorbitan monoisostearate, Polyethylene glycol (20) sorbitan monopalmitate, polyethylene glycol (20) sorbitan monooleate.

Especially advantageous coemulsifiers are glyceryl monostearate, glyceryl monooleate, Diglyceryl monostearate, glyceryl isostearate, polyglyceryl-3-oleate, Polyglyceryl-3 diisostearate, Polyglyceryl-4-isostearate, polyglyceryl-2-dipolyhydroxystearate, Polyglyceryl-4-dipolyhydroxystearate, PEG-30-dipolyhydroxystearate, Diisostearoylpolyglyceryl-3-diisostearate, glycol distearate and polyglyceryl-3-dipolyhydroxystearate, Sorbitan monoisostearate, sorbitan stearate, sorbitan oleate, sucrose distearate, Lecithin, PEG-7 hydrogenated castor oil, cetyl alcohol, stearyl alcohol, Behenyl alcohol, isobehenyl alcohol and polyethylene glycol (2) stearyl ether (Steareth-2), alkyl methicone copolyols and alkyl dimethicone copolyols, especially cetyl dimethicone copolyol, lauryl methicone copolyol.

The Compositions of the invention can one or more of the emulsifiers, co-emulsifiers or solubilizers in amounts of 0.1 to 20 wt .-%, preferably 1 to 15 wt .-% and especially preferably 3 to 10% by weight, based on the finished compositions, contain.

When Stabilizers can Metal salts of fatty acids, such as. Magnesium, aluminum and / or zinc stearate are used, preferably in amounts of 0.1 to 10 wt .-%, preferably 0.5 to 8 wt .-% and particularly preferably 1 to 5 wt .-%, based on the finished compositions.

When Cationic polymers are those known by the INCI name "Polyquaternium", in particular Polyquaternium-31, Polyquaternium-16, Polyquaternium-24, Polyquaternium-7, Polyquaternium-22, Polyquaternium-39, Polyquaternium-28, Polyquaternium-2, Polyquaternium-10, Polyquaternium-11, as well as Polyquaternium 37 & mineral oil & PPG trideceth (Salcare SC95), PVP-dimethylaminoethyl methacrylate copolymer, guar hydroxypropyltriammonium chlorides, as well as calcium alginate and ammonium alginate. Furthermore, can be used become cationic cellulose derivatives; cationic starch; copolymers of diallyl ammonium salts and acrylamides; quaternized vinylpyrrolidone / vinylimidazole polymers; Condensation products of polyglycols and amines; quaternierte collagen; quaternized wheat polypeptides; polyethyleneimines; cationic silicone polymers, e.g. amidomethicones; copolymers of adipic acid and Dimethylaminohydroxy-propyldiethylentriamin; Polyaminopolyamide and cationic chitin derivatives such as chitosan.

The Compositions of the invention can one or more of the above-mentioned cationic polymers in quantities from 0.1 to 5 wt .-%, preferably 0.2 to 3 wt .-% and especially preferably 0.5 to 2% by weight, based on the finished compositions, contain.

Furthermore, the compositions of the invention may contain film formers which are selected depending on the application of salts of phenylbenzimidazole sulfonic acid, water-soluble polyurethanes, for example C ₁₀ -Polycarbamylpolyglycerylester, polyvinyl alcohol, water-soluble acrylic acid polymers / copolymers or their esters or salts, for example partial ester copolymers of acrylic / methacrylic acid, water-soluble cellulose, for example hydroxymethylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, water-soluble Quaterniums, polyquaterniums, carboxyvinyl polymers, such as carbomers and salts thereof, polysaccharides, for example polydextrose and glucan, vinyl acetate / crotonate, 60 (Clariant) available for example under the trade name Aristoflex ^® A.

The Compositions of the invention can one or more film formers in amounts of from 0.1 to 10% by weight, preferably from 0.2 to 5% by weight, and more preferably from 0.5 to 3 wt .-%, based on the finished compositions.

The desired viscosity The compositions can be made by adding thickeners and gelling agents be set. Cellulose ethers are preferably used and other cellulose derivatives (e.g., carboxymethylcellulose, hydroxyethylcellulose), Gelatin, starch and starch derivatives, Sodium alginates, fatty acid polyethylene glycol esters, Agar-agar, tragacanth or dextrin derivatives, especially dextrin esters. Furthermore, metal salts of fatty acids, preferably 12 to 22 C-atoms, for example sodium stearate, sodium palmitate, sodium laurate, Sodium arachidate, sodium behenate, potassium stearate, potassium palmitate, sodium myristate, Aluminum monostearate, hydroxy fatty acids, for example, 12-hydroxystearic acid, 16-hydroxyhexadecanoic acid; fatty acid amides; fatty acid; Dibenzal sorbitol and alcohol soluble Polyamides and polyacrylamides or mixtures thereof. Farther can crosslinked and uncrosslinked polyacrylates such as carbomer, sodium polyacrylates or sulfonic acid-containing Polymers such as ammonium acryloyl dimethyl taurate / VP copolymer use Find.

Prefers contain the compositions of the invention 0.01 to 20 wt .-%, particularly preferably 0.1 to 10 wt .-%, in particular preferably 0.2 to 3 wt .-% and most preferably 0.4 to 2 wt .-% of thickeners or gelling agents.

As superfatting agent can preferably lanolin and lecithin, non-ethoxylated and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, Mono-, di- and triglycerides and / or fatty acid alkanolamides, wherein the the latter simultaneously serve as foam stabilizers used which are preferably in amounts of 0.01 to 10 wt .-%, especially preferably from 0.1 to 5 wt .-% and particularly preferably from 0.5 to 3 wt .-%, based on the finished compositions of the invention.

Antimicrobial agents include cetyltrimethylammonium chloride, cetylpyridinium chloride, benzethonium chloride, diisobutylethoxyethyldimethylbenzylammonium chloride, sodium N-laurylsarcosinate, sodium N-palmethyl sarcosinate, lauroylsarcosine, N-myristoylglycine, potassium N-laurylsarcosine, trimethylammonium chloride, sodium aluminum chlorohydroxylactate, triethyl citrate, tricetylmethylammonium chloride, 2,4,4'-trifluoromethylammonium chloride. Trichloro-2'-hydroxydiphenyl ether (triclosan), phenoxyethanol, 1,5-pentanediol, 1,6-hexanediol, 3,4,4'-trichlorocarbanilide (triclocarban), diaminoalkylamide, for example L-lysine hexadecylamide, citrate heavy metal salts, salicylates, piroctose, in particular Zinc salts, pyrithiones and their heavy metal salts, in particular zinc pyrithione, zinc phenol sulfate, farnesol, ketoconazole, oxiconazole, bifonazoles, butoconazoles, cloconazoles, clotrimazoles, econazoles, enilconazoles, fenticonazoles, isoconazoles, miconazoles, sulconazoles, ticonoconazole fluconazoles, itraconazoles, terconazoles, naftifines and terbinafines Selenium disulphide and octopirox ^®, iodopropynyl butylcarbamate, methylchloroisothiazolinone, methylisothiazolinone, Methyldibromo glutaronitrile, AgCl, Chloroxylenol, Na salt of diethylhexyl, sodium benzoate, and phenoxyethanol, benzyl alcohol, phenoxyisopropanol, parabens, preferably butyl, ethyl, methyl and propyl paraben as well as their Na Salts, pentanediol, 1,2-octanediol, 2-bromo-2-nitropropane-1,3-diol, ethylhexylglycerol, benzyl alcohol, sorbic acid, benzoic acid, lactic acid, imidazolidinyl urea, diazolidinyl urea, dimethyloldimethylhydantoin (DMDMH), sodium salt of hydroxymethylglycinate, hydroxyethylglycine sorbic acid and combinations of these active substances are used.

The Compositions of the invention contain the antimicrobial agents preferably in amounts of 0.001 to 5 wt .-%, particularly preferably from 0.01 to 3 wt .-% and particularly preferably from 0.1 to 2 wt .-%, based on the finished Compositions.

The compositions of the invention may further biogenic agents selected from plant extracts such as aloe vera, as well as local anesthetics, antibiotics, anti-inflammatories, anti-allergic agents, corticosteroids, sebostatics, bisabolol ^®, allantoin, phytantriol ^®, proteins, vitamins selected from niacin, biotin, vitamin B2 , Vitamin B3, Vitamin B6, Vitamin B3 derivatives (salts, acids, esters, amides, alcohols), Vitamin C and Vitamin C derivatives (salts, acids, esters, amides, alcohols), preferably as the sodium salt of the monophosphoric acid ester of ascorbic acid or as the magnesium salt of the phosphoric acid ester of ascorbic acid, tocopherol and tocopherol acetate, as well as vitamin E and / or its derivatives.

The Compositions of the invention can biogenic agents preferably in amounts of 0.001 to 5 wt .-%, especially preferably from 0.01 to 3 wt .-% and particularly preferably from 0.1 to 2 wt .-%, based on the finished compositions.

The Compositions of the invention can Astringents, preferably magnesium oxide, aluminum oxide, titanium dioxide, Zirconia and zinc oxide, oxide hydrates, preferably alumina hydrate (Boehmite) and Hydroxides, preferably of calcium, magnesium, aluminum, titanium, zirconium or zinc, and aluminum chlorohydrates preferably in amounts of 0 to 50 wt .-%, particularly preferably in amounts of 0.01 to 10 wt .-% and especially preferably in amounts of from 0.1 to 10% by weight. Preferred deodorants are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10 wt .-%.

The Compositions of the invention can as pigments / micropigments and as sunscreen microfine Titanium dioxide, mica titanium oxide, iron oxides, mica iron oxide, zinc oxide, Silicon oxides, ultramarine blue, chromium oxides.

The compositions according to the invention may contain sunscreen filters, preferably selected from 4-aminobenzoic acid, 3- (4'-trimethylammonium) benzylidene-boran-2-one methylsulfate, Camphor benzalkonium methosulfate, 3,3,5-trimethylcyclohexylsalicylate, 2-hydroxybenzyl 4-methoxybenzophenone, 2-phenylbenzimidazole-5-sulfonic acid and its potassium, sodium and triethanolamine salts, 3,3 '- (1,4-phenylenedimethine) bis- (7,7-dimethyl-2-oxobicyclo [2.2.1 ] heptane-1-methanesulfonic acid) and its salts, 1- (4-tert-butylphenyl) -3- (4-methoxyphenyl) propane-1,3-dione, 3- (4'-sulfo) -benzylidene-bornanone 2-one and its salts, 2-cyano-3,3-diphenyl-2-ethylhexyl acrylate, polymers of N- [2 (and 4) - (2-oxoborn-3-ylidenemethyl) benzyl] -acrylamide, 4-Methoxycinnamic acid 2-ethylhexyl ester, ethoxylated ethyl 4-aminobenzoate, 4-methoxycinnamic acid isoamyl ester, 2,4,6-tris [p (2-ethylhexyloxycarbonyl) anilino] -1,3 , 5-triazine, 2- (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyloxy) -disilox anyl) -propyl) phenol, 4,4 '- [(6- [4 - ((1,1-dimethylethyl) amino-carbonyl) phenylamino] -1,3,5-triazine-2,4-yl) diimino ] bis (benzoic acid 2-ethylhexyl ester), benzophenone-3, benzophenone-4 (acid), 3- (4'-methylbenzylidene) -D, L-camphor, 3-benzylidene-camphor, 2-ethylhexyl salicylate, 4- Dimethylaminobenzoic acid 2-ethylhexyl ester, hydroxy-4-methoxybenzophenone-5-sulfonic acid (sulfisobenzone) and the sodium salt, 4-Isopropylbenzylsali cylate, N, N, N-trimethyl-4- (2-oxoborn-3-ylidenemethyl) anilium methyl sulphate, homosalates (INN), oxybenzone (INN), 2-phenylbenzimidazole-5-sulphonic acid and its sodium, potassium, and triethanolamine salts, octylmethoxycinnamic acid, isopentyl-4-methoxycinnamic acid, isoamyl-p-methoxycinnamic acid, 2,4,6-trianilino (p-carbo-2'-ethylhexyl-1'-oxy) -1,3,5-triazines (Octyl triazone) Phenol, 2-2 (2H-benzotriazol-2-yl) -4-methyl-6- (2-methyl-3- (1,3,3,3-tetramethyl-1- (trimethylsilyl) oxy) -disiloxanyl ) propyl (drometrizole trisiloxane) benzoic acid, 4,4 - ((6 - ((((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4-diyl) diimino) bis (2-ethylhexyl) ester) benzoic acid, 4,4 - ((6 - ((((1,1-dimethylethyl) amino) carbonyl) phenyl) amino) -1,3,5-triazine-2,4- diyl) diimino) bis, bis (2-ethylhexyl) ester), 3- (4'-methylbenzylidene) -D, L-camphor (4-methylbenzylidene camphor), benzylidene-camphorsulfonic acid, octocrylene, polyacrylamidomethyl-benzylidene-camphor, 2- Ethylhexyl salicylate (octyl salicylate), 4-dimethyl-aminobenzoic acid ethyl 2-hexyl ester (octyl dimethyl PABA), PEG-25 PABA, 2-hydroxy-4-methoxybenzo-phenone-5-sulfonic acid (benzophenone-5) and the Na salt, 2,2'-methylene-bis-6 - (2H-benzotriazol-2yl) -4- (tetramethyl-butyl) -1,1,3,3-phenol, sodium salt of 2-2'-bis (1,4-phenylene) 1H-benzimidazole-4,6 -disulfonic acid, (1,3,5) -triazine-2,4-bis ((4- (2-ethyl-hexyloxy) -2-hydroxy) -phenyl) -6- (4-methoxyphenyl), 2-ethylhexyl 2-cyano-3,3-diphenyl-2-propenoate, glyceryl octanoate, di-p-methoxycinnamic acid, p-aminobenzoic acid and its esters, 4-tert-butyl-4'-methoxydibenzoylmethane, 4- (2-β- Glucopyranoxy) propoxy-2-hydroxybenzophenone, octyl salicylate, methyl 2,5-diisopropylcinnamic acid, cinoxate, dihydroxy-dimethoxybenzophenone, disodium salt of 2,2'-dihydroxy-4,4'-dimethoxy-5,5'-disulfobenzophenone, dihydroxybenzophenone, 1,3,4-dimethoxyphenyl-4,4-dimethyl-1,3-pentanedione, 2-ethylhexyl-dimethoxybenzylidene-dioxoimidazolidine propionate, methylene-bis-benztriazolyl tetramethylbutylphenol, phenyldibenzimidazole tetrasulfonate, bis-ethylhexyl oxyphenol methoxyphenol triazine, tetrahydroxybenzophenones, terephthalylidenedicampheresulfonic acid, 2,4,6-tris [4,2-ethylhexyloxycarbonyl) anilino] -1,3,5-triazine, methyl bis (trimethylsiloxy) silyl-isopentyl trimethoxycinnamic acid, Amyl p-dimethylaminobenzoate, amyl p-dimethylamino benzoate, 2-ethylhexyl p-dimethylaminobenzoate, isopropyl p-methoxycinnamic acid / diisopropyl cinnamic acid ester, 2-ethylhexyl p-methoxycinnamic acid, 2-hydroxy-4-methoxybenzophenone, 2-hydroxybenzoate 4-methoxybenzophenone-5-sulfonic acid and the trihydrate, and also 2-hydroxy-4-methoxybenzophenone-5-sulfonate sodium salt and phenylbenzimidazole-sulfonic acid.

The Amount of the aforementioned sunscreen filters (one or more compounds) in the compositions preferably from 0.001 to 30% by weight, particularly preferably from 0.05 to 20 Wt .-% and in particular 1 to 10 wt .-%, based on the total weight the finished composition.

The compositions of the invention may contain antioxidants, preferably selected from amino acids (eg glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (eg urocanic acid) and their derivatives, peptides such as DL-carnosine, D-carnosine, L-carnosine and their derivatives (eg, anserine), carotenoids, carotenes (eg, α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and its derivatives, lipoic acid and its derivatives (eg, dihydrolipoic acid), aurothioglucose, propylthiouracil, and other thiols (eg, thioredoxin, glutathione, Cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) as well as their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (eg, esters, ethers, peptides, lipids, nucleotides, nucleosides and salts), as well as sulfoximine compounds (eg, buthionine sulfoximines, homocysteine sulfoximine, buthione sulfones, penta, hexa, heptathionine sulfoximine) in very low compatible dosages, furthermore (metal) chelators (eg α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (eg citric acid, lactic acid, malic acid), humic acid , Bile acids, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (eg γ-linolenic acid, linoleic acid, oleic acid), folic acid and its derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (eg Ascorbyl palmitate, Mg ascorbyl phosphate, ascorbyl acetate), tocopherols and derivatives (eg, vitamin E acetate), vitamin A and derivatives (vitamin A palmitate), and benzylic resin, benzylic acid, rutinic acid and their derivatives, α-glycosylrutin, ferulic acid, furfurylidene glucitol, carnosine, Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, uric acid and the derivatives, mannose and their derivatives, zinc and its derivatives (eg ZnO, ZnSO ₄ ), selenium and its derivatives (eg selenium methionine), stilbenes and their derivatives (eg stilbene oxide, trans-stilbene oxide), superoxide dismutase and the inventively suitable derivatives (Salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these substances.

The Antioxidants can protect the skin and hair from oxidative stress. Preferred antioxidants are vitamin E and its derivatives as well as vitamin A and its Derivatives.

The amount of the one or more antioxidants in the compositions according to the invention is preferably 0.001 to 30 wt .-%, particularly preferably 0.05 to 20 wt .-% and in particular preferably from 1 to 10% by weight, based on the total weight of the composition.

Of Further can Humectants, selected from the sodium salt of 2-pyrrolidone-5-carboxylate (NaPCA), guanidine; glycolic and their salts, lactic acid and their salts, glucosamines and their salts, lactamide monoethanolamine, Acetamide monoethanolamine, urea, hydroxy acids, panthenol and its Derivatives, for example D-panthenol (R-2,4-dihydroxy-N- (3-hydroxypropyl) -3,3-dimethylbutamide), DL-panthenol, calcium pantothenate, panthetin, pantotheine, panthenyl ethyl ether, Isopropyl palmitate, glycerol and / or sorbitol are used, preferably in amounts of 0.1 to 15 wt .-% and particularly preferably from 0.5 to 5 wt .-%, based on the finished compositions.

In addition, the Compositions of the invention organic solvents contain. In principle, all organic solvents come on or off polyhydric alcohols into consideration. Alcohols are preferred with 1 to 4 carbon atoms, such as ethanol, propanol, isopropanol, n-butanol, i-butanol, t-butanol, glycerol and mixtures of the above Alcohols used. Further preferred alcohols are polyethylene glycols with a molecular weight under 2000. In particular, is a use of polyethylene glycol with a molecular weight between 200 and 600 and in amounts up to 45% by weight and of polyethylene glycol with a molecular weight between 400 and 600 in amounts of 5 to 25 wt .-% preferred. Further suitable solvents are, for example, triacetin (glycerol triacetate) and 1-methoxy-2-propanol.

The dyes and pigments contained in the compositions according to the invention, both organic and inorganic dyes, are selected from the corresponding positive list of the Cosmetics Ordinance or the EC List of cosmetic colorants. Chemical or other name CIN colour Pigment Green 10006 green Acid Green 1 10020 green 2,4-Dinitrohydroxynaphtalin-7-sulfonic acid 10316 yellow Pigment Yellow 1 11680 yellow Pigment Yellow 3 11710 yellow Pigment Orange 1 11725 orange 2,4-dihydroxyazobenzene 11920 orange Solvent Red 3 12010 red 1- (2'-chloro-4'-nitro-1'-phenylazo) -2-hydroxynaphthalene 12085 red Pigment Red 3 12120 red Ceresrot; Sudan Red; Fat Red G 12150 red Pigment Red 112 12370 red Pigment Red 7 12420 red Pigment Brown 1 12480 brown 4- (2'-methoxy-5'-sulfosäurediethylamid-1'-phenylazo) -3-hydroxy-5 '' - chloro-2 '', 4 '' - dimethoxy-2-naphthoic acid anilide 12490 red Disperse Yellow 16 12700 yellow 1- (4-Sulfo-1-phenylazo) -4-amino-brezol-sulfonic acid 13015 yellow 2,4-dihydroxy-azobenzene-4'-sulfonic acid 14270 orange 2- (2,4-Dimethylphenylazo-5-sulfosäurse) -1-hydroxynaphthalene-4-sulfonic acid 14700 red 2- (4-sulfo-1-naphthylazo) -1-naphthol-4-sulfonic acid 14720 red 2- (6-sulfo-2,4-xylylazo) -1-naphthol-5-sulfonic acid 14815 red 1- (4'-sulfophenylazo) -2-hydroxynaphthalene 15510 orange Chemical or other name CIN colour 1- (2-sulfonic acid 4-chloro-5-carboxylic acid-1-phenylazo) -2-hydroxynaphthalene 15525 red 1- (3-methyl-phenylazo-4-sulfonic acid) -2-hydroxynaphthalene 15580 red 1- (4 ', (8') - Sulfosäurenaphthylazo) -2-hydroxynaphthalene 15620 red 2-hydroxy-1,2'-azonaphthalene-1'-sulfonic acid 15630 red 3-hydroxy-4-phenylazo-2-naphthylcarboxylic acid 15800 red 1- (2-sulfo-4-methyl-1-phenylazo) -2-naphthylcarboxylic acid 15850 red 1- (2-sulfo-4-methyl-5-chloro-1-phenylazo) -2-hydroxynaphthalene-3-carboxylic acid 15865 red 1- (2-sulfo-1-naphthylazo) -2-hydroxynaphthalene-3-carboxylic acid 15880 red 1- (3-sulfo-1-phenylazo) -2-naphthol-6-sulfonic acid 15980 orange 1- (4-Sulfo-1-phenylazo) -2-naphthol-6-sulfonic acid 15985 yellow Allura Red 16035 red 1- (4-sulfo-1-naphthylazo) -2-naphthol-3,6-disulfonic acid 16185 red Acid Orange 10 16230 orange 1- (4-sulfo-1-naphthylazo) -2-naphthol-6,8-disulfonic acid 16255 red 1- (4-sulfo-1-naphthylazo) -2-naphthol-3,6,8 -tisulfosäure, 16290 red 8-amino-2-phenylazo-1-naphthol-3,6-disulfonic acid 17200 red Acid Red 1 18050 red Acid Red 155 18130 red Acid Yellow 121 18690 yellow Acid Red 180 18736 red Acid Yellow 11 18820 yellow Acid Yellow 17 18965 yellow 4- (4-Sulfo-1-phenylazo) -1- (4-sulfophenyl) -5-hydroxyphrazolon-3-carboxylic acid 19140 yellow Pigment Yellow 16 20040 yellow 2,6- (4'-sulfo-2 '', 4 '' - dimethyl) -bisphenylazo) of 1,3-dihydroxybenzene 20170 orange Acid Black 1 20470 black Pigment Yellow 13 21100 yellow Chemical or other name CIN colour Pigment Yellow 83 21108 yellow Solvent Yellow 21230 yellow Acid Red 163 24790 red Acid Red 73 27290 red 2- [4 '- (4''Sulfo-1''- phenylazo) -7'-sulfo-1'-naphthylazo] -1-hydroxy-7-3,6-disulfonic acid aminoaphthalin- 27755 black 4 '- [(4''-sulfo-1''- phenylazo) -7'-sulfo-1'-naphthylazo] -1-hydroxy-8-acetyl-aminonaphthalene-3,5-disulfonic acid 28440 black Direct Orange 34, 39, 44, 46, 60 40215 orange Food Yellow 40800 orange trans-β-apo-8'-carotenaldehyde (C ₃₀ ) 40820 orange trans-apo-8'-carotenoic acid (C ₃₀ ) ethyl ester 40825 orange canthaxanthin 40850 orange Acid Blue 1 42045 blue 2,4-disulfo-5-hydroxy-4'-4 '' - bis (diethylamino) triphenylcarbinol 42051 blue 4 - [(- 4-N-ethyl-p-sulfobenzylamino) -phenyl- (4-hydroxy-2-sulfophenyl) - (methylene) -1- (N-ethylN-p-sulfobenzyl) -2,5-cyclohexadienimine] 42053 green Acid blue 7 42080 blue (N-ethyl-p-sulfobenzyl-amino-phenyl- (2-sulfophenyl) methylene (N-ethyl-Np-sulfobenzyl) -cyclohexadienimin 42090 blue Acid Green 9 42100 green Diethyl-di-sulfobenzyl-di-4-amino-2-chloro-di-2-methylfuchsonimonium 42170 green Basic Violet 14 42510 violet Basic Violet 2 42520 violet 2'-methyl-4 '- (N-ethyl-Nm-sulfobenzyl) amino-4''- (N-diethyl) amino-2-methyl-N-ethyl-Nm-sulfobenzyl-fuchsonimmonium 42735 blue 4 '- (N-Dimethyl) amino-4''- (N-phenyl) -aminonaphtho-N-dimethyl-fuchsonimmonium 44045 blue Chemical or other name CIN colour 2-hydroxy-3,6-disulfo-4,4'-bis-dimethylaminonaphtofuchsinimmonium 44090 green Acid red 45100 red 3- (2'-methylphenylamino) -6- (2-methyl-4'-sulfophenylamino) -9- (2 '' - carboxyphenyl) -xantheniumsalz 45190 violet Acid Red 50 45220 red Phenyl-2-oxyfluoron-2-carboxylic acid 45350 yellow 4.5-Dibromofluorescein 45370 orange 2,4,5,7-Tetrabromfluorescein 45380 red Solvent dye 45396 orange Acid Red 98 45405 red 3 ', 4', 5 ', 6'-tetrachloro-2,4,5,7-tetrabromfluorescein 45410 red 4.5-Diiodfluorescein 45425 red 2,4,5,7-Tetraiodfuorescein 45430 red quinophthalone 47000 yellow Quinophthalone disulphonic 47005 yellow Acid Violet 50 50325 violet Acid Black 2 50420 black Pigment Violet 23 51319 violet 1,2-dioxyanthraquinone, calcium-aluminum complex 58000 red 3-Oxypyren-5,8,10-sulfonic acid 59040 green 1-hydroxy-4-N-phenyl-aminoanthraquinone 60724 violet 1-hydroxy-4- (4'-methylphenylamino) anthraquinone 60725 violet Acid Violet 23 60730 violet 1,4-di (4'-methylphenylamino) anthraquinone 61565 green 1,4-bis (o-sulfo-p-toluidine) anthraquinone 61570 green Acid Blue 80 61585 blue Acid Blue 62 62045 blue N, N'-dihydro-1,2,1 ', 2'-anthrachinonazin 69800 blue Vat Blue 6; Pigment Blue 64 69825 blue Vat Orange 7 71105 orange indigo 73000 blue Chemical or other name CIN colour Indigo-disulfonic 73015 blue 4,4'-dimethyl-6,6'-dichlorothioindigo 73360 red 5,5'-dichloro-7,7'-dimethylthioindigo 73385 violet Quinacridone Violet 19 73900 violet Pigment Red 122 73915 red Pigment Blue 16 74100 blue phthalocyanines 74160 blue Direct Blue 86 74180 blue chlorinated phthalocyanines 74260 green Natural Yellow 6.19; Natural Red 1 75100 yellow Bixin, nor-bixin 75120 orange lycopene 75125 yellow trans-alpha, beta or gamma-carotene 75130 orange Keto and / or hydroxyl derivatives of carotene 75135 yellow Guanine or pearlescing agent 75170 White 1,7-bis (4-hydroxy-3-methoxyphenyl) 1,6-heptadiene-3,5-dione 75300 yellow Complex salt (Na, Al, Ca) of karmic acid 75470 red Chlorophyll a and b; Copper compounds of chlorophylls and chlorophyllins 75810 green aluminum 77000 White alumina hydrate 77002 White hydrous aluminum silicates 77004 White ultramarine 77007 blue Pigment Red 101 and 102 77015 red barium sulfate 77120 White Bismuth oxychloride and its mixtures with mica 77163 White calcium carbonate 77220 White calcium sulphate 77231 White carbon 77266 black Pigment Black 9 77267 black Carbo medicinalis vegetabilis 77268: 1 black chromium 77288 green Chemical or other name CIN colour Chromium oxide, hydrous 77289 green Pigment Blue 28, Pigment Green 14 77346 green Pigment Metal 2 77400 brown gold 77480 brown Iron oxides and hydroxides 77489 orange Iron oxides and hydroxides 77491 red iron oxide 77492 yellow iron oxide 77499 black Mixtures of iron (II) and iron (III) hexacyanoferrate 77510 blue Pigment White 18 77713 White Mangananimoniumdiphosphat 77742 violet Manganese phosphate; Mn ₃ (PO ₄ ) ₂ .7H ₂ O 77745 red silver 77820 White Titanium dioxide and its mixtures with mica 77891 White zinc oxide 77947 White 6,7-dimethyl-9- (1'-D-ribityl) -isoalloxazine, lactoflavin yellow caramel brown Capsanthin, Capsorubin orange betanin red Benzopyrilium salts, anthocyanins red Aluminum, zinc, magnesium, and calcium stearate White Bromthymolblau blue bromocresol green Acid Red 195 red

Further advantageous are oil-soluble natural dyes, such as. Paprika extracts, β-carotene and cochineal.

Also advantageously used are pearlescent pigments, for example, fish-silver (guanine / hypoxanthine mixed crystals from fish scales) and mother-of-pearl (ground mussel shells), monocrystalline pearlescent pigments, such as bismuth oxychloride (BiOCl), layer-substrate pigments, eg mica / metal oxide, silver-white pearlescent pigments of TiO ₂ , interferon pigments (TiO ₂ , different layer thickness), color luster pigments (Fe ₂ O ₃ ) and combination pigments (TiO ₂ / Fe ₂ O ₃ , TiO ₂ / Cr ₂ O ₃ , TiO ₂ / Berliner Blue, TiO ₂ / carmine).

In the context of the present invention, effect pigments are to be understood as meaning pigments which, by virtue of their refractive properties, cause particular optical effects. Effect pigments lend the treated surface (skin, hair, mucous membrane) gloss or glitter effects or can optically hide skin irregularities and skin wrinkles through diffuse light scattering. As a particular embodiment of the effect pigments, interference pigments are preferred. Particularly suitable effect pigments are, for example, mica particles coated with at least one metal oxide. In addition to mica, a phyllosilicate, silica gel and other SiO ₂ modifications are also suitable as carriers. A metal oxide frequently used for coating is, for example, titanium oxide, to which iron oxide may be added, if desired. The size and shape (eg spherical, ellipsoidal, flattened, even, uneven) of the pigment particles as well as the thickness of the oxide coating can influence the reflection properties. Other metal oxides, for example bismuth oxychloride (BiOCl), and the oxides of, for example, titanium, in particular the TiO ₂ modifications anatase and rutile, aluminum, tantalum, niobium, zirconium and hafnium. Also with magnesium fluoride (MgF ₂ ) and calcium fluoride (fluorspar, CaF ₂ ) effect pigments can be produced.

The effects can be controlled both by the particle size and by the particle size distribution of the pigment ensemble. Suitable particle size distributions range, for example, from 2-50 μm, 5-25 μm, 5-40 μm, 5-60 μm, 5-95 μm, 5-100 μm, 10-60 μm, 10-100 μm, 10-125 μm. 20-100 μm, 20-150 μm, and <15 μm. A broader particle size distribution, for example from 20-150 microns, produces glittering effects, while a narrower Particle size distribution of <15 microns ensures a uniform silky appearance.

The Compositions of the invention contain effect pigments, preferably in amounts of from 0.1 to 20% by weight, more preferably from 0.5 to 10% by weight and especially preferred from 1 to 5 wt .-%, each based on the total weight of the composition.

When deodorants are preferred are allantoin and bisabolol. These are preferably used in amounts of 0.0001 to 10 wt .-%.

When Fragrance or perfume oils can be individual Fragrance compounds, e.g. the synthetic products of the type the esters, ethers, aldehydes, ketones, alcohols and hydrocarbons be used. Fragrance compounds of the ester type are e.g. Benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, Dimethylbenzylcarbinylacetate, phenylethylacetate, linalylbenzoate, Benzyl formate, ethyl methyl phenyl glycinate, allyl cyclohexyl propionate, Styrallyl propionate and Benzylsalicylate. For example, the ethers include Benzyl ethyl ether, to the aldehydes e.g. the linear alkanals with 8 to 18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, Cyclamehaldehyde, Hydroxycitronellal, Lilial and Bourgeonal, too ketones e.g. the ionones, alpha isomethyl ionone and methyl cedryl ketone, to the alcohols anethol, citronellol, eugenol, geranion, linalol, Phenylethyl alcohol and terpineol, the hydrocarbons include mainly Terpenes and balms. Preference is given to mixtures of different fragrances used, which together create an appealing scent.

Perfume oils can also natural Contain fragrance mixtures, such as those from plant or animal Accessible to sources are, e.g. Pine, citrus, jasmine, lily, rose, or ylang-ylang oil. Also essential oils lesser Volatility, which are mostly used as aroma components, are suitable as Perfume oils, e.g. Sage oil, Chamomile oil, Clove oil, Melissa oil Mint oil, Cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil and ladanum oil.

When pearlescing component are preferably suitable fatty acid monoalkanolamides, fatty acid dialkanolamides, Monoesters or diesters of alkylene glycols, in particular ethylene glycol and / or propylene glycol or its oligomers, with higher fatty acids, such as e.g. palmitic acid, stearic acid and behenic acid, monoester or polyesters of glycerol with carboxylic acids, fatty acids and their metal salts, Ketosulfone or mixtures of these compounds. Especially preferred are ethylene glycol distearates and / or polyethylene glycol distearates with an average of 3 glycol units.

Provided the compositions of the invention pearlescing compounds, these are preferred in in an amount of 0.1 to 15% by weight, and more preferably in one Amount of 1 to 10 wt .-% in the compositions of the invention included.

When acids or alkalis for pH adjustment are preferably mineral acids, for example HCl, inorganic bases, for example NaOH or KOH, and organic acids, preferably citric acid, used.

The The following examples and applications are intended to explain the invention in more detail without but to limit it to. All percentages are by weight (% by weight).

Production examples, general working instructions:

at the preparation of the phosphoric acid esters according to the invention become phosphoric acid (85%), diol and fatty alcohol ethoxylate used in a certain molar ratio. For this purpose, all starting materials in a stirring apparatus with heating mushroom, Auskreiser with cooler and vacuum connection presented. The mixture is heated to 100 ° C, evacuated three times to 100 mbar and then again with nitrogen ventilated. After a further 4 hours inertization (nitrogen introduction of 20 liters / hour) at 100 ° C the batch is heated under nitrogen inlet to 230 ° C. and esterified (water discharge). The reaction times are 24 to 42 hours (from 230 ° C Esterification temperature calculated), in particular 40 hours. The Residual acid number is then <3 mg KOH / g. This corresponds to about 93 to 96 conversion (based on starting acid number). After completion of the reaction, the product is cooled to 80 ° C, poured into a bowl and crushed the solidified melt.

Example 1:

• Ester from 11.5 g phosphoric acid, 197.5 g polyglycol 4000 and 296.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in a molar ratio 2: 1: 4 (formula E ₂ ), residual acid number: 1.5 mg KOH / g (96% conversion), ³¹ P-NMR: diester / triester = 13/87 mol%.

Example 2:

• Ester from 13.8 g phosphoric acid, 316.1 g polyglycol 4000 and 296.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 3: 2: 5 (formula E ₂ M), residual acid number : 1.9 mg KOH / g (94% conversion), ³¹ P-NMR: diester / triester = 18/82 mol%.

Example 3:

• Ester of 15.4 g of phosphoric acid, 395.1 g of polyglycol 4000 and 293.3 g of ceteareth-25 (C _16/18 fatty alcohol + 25 moles of ethylene oxide) in a molar ratio 4: 3: 6 (formula E ₂ M ₂ and E ₃ V ), Residual acid number: 2.3 mg KOH / g (93% conversion), ³¹ P-NMR: diester / triester = 18/82 mol%.

Example 4:

• Ester from 47.8 g of phosphoric acid, 1716.8 g of polyglycol 6000 and 515.9 g of ceteareth-11 (C _16/18 fatty alcohol + 11 moles of ethylene oxide) in a molar ratio 3: 2: 5 (formula E ₂ M ₂ and E ₃ V ), Residual acid number: 2.3 mg KOH / g (93% conversion), ³¹ P-NMR: diester / triester = 20/80 mol%.

Example 5:

• Ester from 13.8 g phosphoric acid, 117.5 g polyglycol 1500 and 425.0 g ceteareth-50 (C _16/18 fatty alcohol + 50 mol ethylene oxide) in the molar ratio 3: 2: 5 (formula E ₂ M ₂ and E ₃ V ), Residual acid number: 1.9 mg KOH / g (94% conversion), ³¹ P-NMR: diester / triester = 16/84 mol%.

Example 6:

• Ester from 11.5 g phosphoric acid, 73.4 g polyglycol 1500 and 296.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 2: 1: 4 (formula E ₂ ), residual acid number: 2.5 mg KOH / g (94% conversion), ³¹ P-NMR: diester / triester = 13/87 mol%.

Example 7:

• Ester from 11.5 g phosphoric acid, 409.5 g polyglycol 8000 and 296.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 2: 1: 4 (formula E ₂ ), residual acid number: 1.1 mg KOH / g (95% conversion), ³¹ P-NMR: diester / triester = 13/87 mol%.

Example 8:

• Ester from 13.8 g of phosphoric acid, 117.4 g of polyglycol 1500 and 296.0 g of ceteareth-25 (C _16/18 fatty alcohol + 25 moles of ethylene oxide) in a molar ratio 3: 2: 5 (formula E ₂ M ₂ and E ₃ V , Residual acid number: 2.4 mg KOH / g (95% conversion), ³¹ P-NMR: diester / triester = 13/87 mol%.

Example 9:

• Ester from 13.8 g phosphoric acid, 655.2 g polyglycol 8000 and 296.0 g ceteareth-25 (C _16/18 fatty alcohol + 25 mol ethylene oxide) in the molar ratio 3: 2: 5 (formula E ₂ M ₂ and E ₃ V , Residual acid number: 1.0 mg KOH / g (95% conversion), ³¹ P-NMR: diester / triester = 11/89 mol%.

Example 10:

• Ester of 15.4 g of phosphoric acid, 146.8 g of polyglycol 1500 and 293.3 g of ceteareth-25 (C _16/18 fatty alcohol + 25 moles of ethylene oxide) in a molar ratio 4: 3: 6 (formula E ₂ M ₂ and E ₃ V ), Residual acid number: 3.7 mg KOH / g (93% conversion), ³¹ P-NMR: diester / triester = 16/84 mol%.

Example 11:

• Ester of 15.4 g of phosphoric acid, 819.0 g of polyglycol 8000 and 293.3 g of ceteareth-25 (C _16/18 fatty alcohol + 25 moles of ethylene oxide) in a molar ratio 4: 3: 6 (formula E ₂ M ₂ and E ₃ V ), Residual acid number: 1.4 mg KOH / g (93% conversion), ³¹ P-NMR: diester / triester = 19/81 mol%.

Comparative Examples:

• n. b. nicht bestimmt; RT: Raumtemperatur

As comparative examples, PEG-150 pentaerythrityl tetrastearate (Crothix), PEG-150 Polyglyceryl-2 tristearate (Genapol ^® DAT 100) and PEG 150 distearate (Rewopal ^® PEG 6000 DS) is used, typical ethoxylated fatty acid ester. The viscosity was measured at 20 ° C with a Brookfield type RVT viscometer at 20 rpm immediately after preparation of the solutions to be measured ("viscosity immediately") and after storage of the corresponding solutions. Table 1: Viscosity 6 wt .-% aqueous solutions of Preparation Examples 1 to 11 compared to market products product Viscosity immediately [mPa · s] clarity Viscosity after 3 months storage at RT [mPa.s] example 1 76000 Clear nb Example 2 76000 Clear 38200 Example 3 67500 Clear 34200 Example 4 158000 Clear nb Example 5 103000 Clear nb Example 6 17600 Clear nb Example 7 47200 Clear 41600 Example 8 73000 Clear nb Example 9 36200 Clear 29400 Example 10 79000 Clear 75500 Example 11 13500 Clear 10800 PEG-150 pentaerythritylterastearate 6650 Slightly cloudy, precipitation 990 PEG-150 polyglyceryl-2-tristearate 65 Cloudy, rainfall nb PEG-150 distearate 3900 cloudy nb

• nb not determined; RT: room temperature

• n. b. nicht bestimmt

In Table 1, it can be seen that the inventive phosphoric esters according to Examples 1 to 11 compared to the comparative examples on the one hand give clear gels of high viscosity in water, on the other hand, the viscosity reduction during storage is significantly lower than, for example, PEG-150 pentaerythritylterastearate. Table 2: Viscosity 1% by weight solution in sodium laureth ether sulfate with 2 ethylene oxide units (INCI: sodium laureth sulfate): cocamidopropyl betaine 8: 2, 15% by weight active ingredient sodium laureth sulfate / cocamidopropyl betaine, pH 4-4.4 product Viscosity immediately [mPa · s] Viscosity after 4 months storage at 50 ° C [mPa · s] example 1 79000 78000 Example 2 45200 68,000 Example 8 38000 nb Example 10 47400 74000 PEG-150 pentaerythrityl tetrastearate 20000 80 PEG-150 polyglyceryl-2-tristearate 23100 110 PEG-150 distearate 2750 45

• nb not determined

In Table 2 it can be seen that the phosphoric esters according to the invention of Examples 1, 2, 8 and 10 compared to the comparative examples in surfactant give gels of high viscosity, which lose no viscosity when stored in contrast to the comparative examples. Formulation Examples: Formulation Example 1 (Facial Cleansing Foam) A stearic acid 1.60% myristic 1.80% lauric acid 0.70% Tegin M 0.50% Glyceryl stearate palmitic 0.70% B water ad 100.00% C potassium hydroxide 0.70% Phosphoric acid ester Example 1 1.00%

production:

• I A at 80 ° C melt.
• II C in B with stirring and at 60 ° C to solve, then give to I.
• III with stirring cooling down.

Formulation Example 2 (Cream Rinse) A Genamin ^® CTAC (Clariant) 6:00 am % Cetrimonium chlorides Hostacerin ^® DGL (Clariant) 1.50% PEG-10 diglyceryl-2 laurate Cetylstearyl alcohol 1.70% paraffin oil 1.00% B water ad 100.00% C Phosphoric acid ester Example 4 1.00% D Perfume 0.30% panthenol 0.30% preservative qs dye qs

production:

• I A at 75 ° C melt.
• II C in B with stirring at 60 ° C to solve.
• III II with stirring to give. Stir cold.
• IV at 40 ° C to add the components of D.
• V Adjust the pH to 4.

Formulation Example 3 (Light Leave on for Hair Tips) A SilCare® Silicone 41M15 (Clariant) 0.30% Caprylyl Methicone B Genapol ^® LA 070 (Clariant) 8.00% Laureth-7 C water ad 100% D Phosphoric acid ester Example 2 2.00% e Biobranil 0.50% Soybean (Glycine Soy) Oil and Wheat (Triticum Vulgare) Bran Lipids glycerin 2.00% panthenol 0.50% F SilCare® ^® Silicone SEA (Clariant) 0.50% Trideceth-9 PG Amodimethicone and Trideceth-12 Genamin ^® CTAC (Clariant) 2.00% Cetrimonium chlorides 0.20% Nipaguard ^® DMDMH (Clariant) DMDMH Hydantoin

production:

• Solubilize I A in B.
• II D in C with stirring at 60 ° C to solve.
• Give III E to II and stir until the solution is clear, then give to I.
• IV to III.

Formulation Example 4 (hydrogen peroxide gel) A Phosphoric acid ester Example 3 5.00% Genapol ^® T 250 (Clariant) 2.00% Ceteareth-25 B water ad 100.00% C phosphoric acid 0.04% sodium 1.00% D Hydrogen peroxide 30% 18.00%

production:

• I A with stirring and heating to 50 ° C in B solve.
• II At 25 ° C Add C.
• III Add D at room temperature.

Formulation Example 5 (Deodorant Gel) A Octopirox® ^® (Clariant) 0.10% Piroctone oil amines B Emulsogen® ^® HCP 049 (Clariant) 10.00% PEG-40 Hydrogenated Castor Oil and Propylene Glycol Perfume 0.20% C water ad 100.00% D Phosphoric acid ester Example 5 3.00% e citric acid qs

production:

• Release I A in B.
• II D in C with stirring and dissolve gently then give II to I.
• III if necessary adjust the pH to 6.0 with E

Formulation Example 6 (Make-Up Remover) A Velsan® ^® P8-3 (Clariant) 5.00% Isopropyl C12-15 Pareth-9 Carboxylate B Hostapon® ^® CGN (Clariant) 2.00% Sodium Cocoyl Glutamate Genagen ^® CAB (Clariant) 3.00% Cocamidopropyl betaines allantoin (Clariant) 0.30% Aristoflex® ^® PEA (Clariant) 1.00% Polypropylene terephthalate 1.6 hexanediol 2.00% 1.2 Propanediol 2.00% Polyglycol 400 (Clariant) 2.00% PEG-8 panthenol 0.50% Lutrol F 127 3.00% Poloxamer 407 preservative qs C Phosphoric acid ester Example 10 1.00% D water ad 100.00% e Genapol ^® LA 070 (Clariant) 2.00% Laureth-7

production:

• I Gradually the components from B to A give and stir, until a clear solution arises.
• II C in D with stirring and dissolve gently II to I.
• III E in I stir.

Formulation Example 7 (Whitening Gel) A water ad 100.00% arginine 1.10% Phosphoric acid ester Example 11 4.00% B dipropylene 8.00% Genapol ^® C 100 (Clariant) 0.60% Coceth-10 Sodium citrate · 2H ₂ O 0.09% Citric acid 10.0% 0.10% Nipagin ^® M (Clariant) 0.20% Methylparaben ascorbic acid-2-glucoside 2.00%

production:

• I mix the components of A and stir and dissolve light heating.
• II Give the components from B to I and solve. If necessary the Heat the formulation slightly.

Formulation Example 8 (Facial Toner) A glycerin 8.00% Polyglycol 400 (Clariant) 5.00% PEG-8 panthenol 0.50% Perfume 0.20% alcohol 8.00% preservative qs allantoin (Clariant) 0.10% Niacinamide 0.10% Extrapon witch hazel 1.00% Water, Witch Hazel Distillate, SD Alcohol 39-C, Butylene Glycols B water ad 100% C Phophorsäureester Example 6 2.00%

production:

• I C in B with stirring and gentle heating to solve.
• II. Add the components from A to I and stir until the formulation is homogeneous is.

Formulation Example 9 (Hair Shampoo) A Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Hostapon® ^® CGN (Clariant) 5.00% Sodium Cocoyl Glutamate Perfume 0.30% B water ad 100.00% C Phosphoric acid ester Example 7 1.50% preservative qs dye qs Genagen ^® CAB (Clariant) 8.00% Cocamidopropyl betaines

production:

• Dissolve I C in B with stirring and heating to 50 ° C.
• II Gradually stir in the components of A in I.
• III if necessary Adjust pH.

Formulation Example 10 (bubble bath) A Genapol ^® LRO liquid (Clariant) 60.00% Sodium Laureth Sulfate B Medialan ^® LD (Clariant) 8.00% Sodium lauroyl sarcosinate Perfume 1.50% Velsan® ^® CG 070 (Clariant) 5.00% PEG-7 glyceryl cocoate C Phosphoric acid ester Example 2 1.00% D water ad 100% e dye qs preservative qs Genagen ^® CAB (Clariant) 6:00 am % Cocamidopropyl betaines

production:

• I Gradually the components of B in A Stir.
• II C in D with stirring and heating to 50 ° C to solve.
• III to give II.
• Stir VI E in III.
• V if necessary Adjust pH.

Formulation Example 11 (O / W Skinmilk) A Hostacerin ^® DGI (Clariant) 2.00% Polyglyceryl-2 sesquiisostearates isopropyl palmitate 4.00% octyldodecanol 4.00% Nipaguard ^® PDU (Clariant) qs Propylene glycol (and) diazolidinyl urea (and) methylparaben (and) propylparaben B Aristoflex® ^® AVC (Clariant) 1.20% Ammonium acryloyldimethyltaurate / VP copolymer C Hostapon® ^® CGN (Clariant) 0.60% Sodium Cocoyl Glutamate water ad 100% D Phosphoric acid ester Example 2 1.00% e Perfume 0.40%

production:

• Dissolve I D in C with stirring and heating to 50 ° C.
• Add II B to A, then add I and stir well.
• Give III E to II.
• IV Finally, homogenize the formulation.

Formulation Example 12 (antiperspirant roll-on) A Phosphoric acid ester Example 2 1.50% B water ad 100.00% C Locron ^® L (Clariant) 8:00 pm % Aluminum Chlorohydrate D Genapol ^® T 250 (Clariant) 5.00% Ceteareth-25 Butylene glycol 3.00% Cetiol OE 1.00% Dicaprylyl ether Glyceryl isostearate 2.00% e SilCare® ^® Silicone SEA (Clariant) 0.50% Trideceth-9 PG Amodimethicone and Trideceth-12

production:

• Dissolve I A in B with stirring and heating to 60 ° C.
• Give II C to I.
• III D at 50 ° C Add melt and II, stirring until a clear solution is.
• IV at 30 ° C E admit.

Formulation Example 12 showed a marked reduction in white residue on clothing after application of skin roll-on to the same formulation but without the phosphoric acid ester of Example 2. Formulation Example 13 (Vitamin C Gel) A Phosphoric acid ester Example 2 1.00% Genapol ^® T 250 (Clariant) 2.00% Ceteareth-25 B water ad 100.00% C ascorbic acid 3.00% D Aristoflex AVC (Clariant) 0.80% Ammonium acryloyldimethyltaurate / VP copolymer

production:

• Release I A in B. with stirring at 50 ° C.
• II C in I stir at room temperature.
• Add III D and stir until a homogeneous gel is formed.

• Konservierungsmittel q.s.

Formulation Example 14 (Shower Bath) A Phosphoric acid ester Example 2 (Clariant) 3.00% Aristoflex® ^® PEA (Clariant) 2.00% Polypropylene terephthalate B water ad 100% C Genapol ^® LRO liquid (Clariant) 30.00% Sodium Laureth Sulfate Genapol ^® LA 030 (Clariant) 1.50% Laureth-3 Hostapon® ^® CLG (Clariant) 5.00% Sodium Lauroyl Glutamate Genagen ^® KB (Clariant) 6:00 am % Coco betaine Perfume 0.30% dye qs

• Preservative qs

production:

• Dissolve I A in B at 50 ° C.
• II Stir the components of C into I successively.
• III if necessary adjust the pH value.

• * neutralisiert mit NaOH auf pH 4.

Formulation Example 15 (Facial Anti-Aging Cream Gel) A Phosphoric acid ester Example 8 (Clariant) 1.00% B water ad 100.00% C paraffin oil 5.00% SilCare ^® Silicone 31M50 (Clariant) 3.00% Caprylyl trimethicone D Aristoflex® ^® AVC (Clariant) 1.80% Ammonium acryloyldimethyltaurate / VP copolymer e Glycolic acid 30% * 6:00 am % Phenonip ^® (Clariant) 0.50% Phenoxyethanol (and) Methylparaben (and) Ethylparaben (and) Butylparaben (and) Propylparaben (and) Isobutylparaben F Genapol ^® LA 070 (Clariant) 2.00% Laureth-7

• * neutralized with NaOH to pH 4.

production:

• Dissolve I A in B with stirring at 50 ° C.
• II D in C stir.
• Stir in III I in II and stir as long until a homogeneous gel is formed.
• IV E in III admit.
• Stir V F into IV and stir as long until the cream gel is homogeneous.

Formulation example 16 (O / W self-tanning cream) A Hostaphat ^® CC 100 (Clariant) 1.0% Cetyl phosphates Glyceryl stearate 0.5% Cetearyl alcohol 0.5% paraffin oil 8.0% isopropyl palmitate 7.0% SilCare ^® Silicone 41M15 (Clariant) 1.0% Caprylyl Methicone B Aristoflex® ^® AVC (Clariant) 1.2% Ammonium acryloyldimethyltaurate / VP copolymer C water ad 100% D Phosphoric acid ester Example 9 (Clariant) 1.0% e Hostapon® ^® CLG (Clariant) 0.5 Sodium Lauroyl Glutamate glycerin 5.0% F Tocopheryl acetate 1.0% Fragrance 0.2 Preservative qs G Dihydroxyacetone 5.0% H water 8.0% I Sodium hydroxide (10% in water) qs

production:

• I A at 80 ° C melt.
• Mix II B in A.
• III D in C at 50 ° C to solve, then admit E.
• Mix IV III in II.
• V Add room temperature at room temperature.
• Release VI G in H. and stir in V.
• VII If necessary, adjust the pH value with I to 4-5.

Formulation Example 17 (O / W Sunscreen Milk) A Hostaphat ^® CK 100 (Clariant) 2.00% Potassium Cetyl Phosphate SilCare ^® Silicone 41M15 (Clariant) 1.00% Caprylyl Methicone stearic acid 0.50% Cetyl alcohol 0.50% Cutina ^® GMS 1.00% Glyceryl stearate Cetiol ^® SN 4.00% Cetearyl isononanoate Velsan ^® CCT (Clariant) 4.00% Caprylic / Capric Triglycerides ^Neo® Heliopan BB 1.50% Benzophenones - 3 Eusolex ^® 6300 4.00% 4-methylbenzylidene camphor B Aristoflex® ^® AVC (Clariant) 0.40% Ammonium acryloyldimethyltaurate / VP copolymer C water ad 100% D Phosphoric acid ester Example 2 (Clariant) 1.00% e glycerin 3.00% Eusolex ^® 232 2.00% Phenylbenzimidazole sulfonic acid Tris (hydroxymethyl) aminomethane 1.10% tromethamine F Tocopheryl acetate 0.50% Phenonip ^® (Clariant) 0.50% Phenoxyethanol (and) Methylparaben (and) Butylparaben (and) Ethylparaben (and) propylparaben Fragrance 0.40%

production:

• I A at 80 ° C melt, then add B
• II D in C at 60 ° C to solve.
• III E in II stir.
• Dissolve IV III in I.
• V At 35 ° C Add F in IV.

• * neutralisiert mit NaOH auf pH 4.

Formulation Example 18 (Facial Anti-Aging Gel) A Genapol® T 250 (Clariant) 1.00% Ceteareth-25 Phosphoric acid ester Example 2 (Clariant) 1.00% B water ad 100% C Aristoflex® ^® AVC (Clariant) 2.00% Ammonium acryloyldimethyltaurate / VP copolymer D Glycolic acid 30% * 6:00 am % Phenonip ^® (Clariant) 0.50% Phenoxyethanol (and) Methylparaben (and) Ethylparaben (and) Butylparaben (and) Propylparaben (and) Isobutylparaben

• * neutralized with NaOH to pH 4.

production:

• Dissolve I A in B with stirring at 50 ° C.
• Add II C and stir until a homogeneous gel is formed.
• Add III D and stir until the gel is homogeneous again.

Claims (22)

A) one or more structural units derived from substances of component a), wherein the substances of component a) are selected from orthophosphoric acid and one or more of its derivatives, and wherein the one or more derivatives of orthophosphoric acid are preferably selected from polyphosphoric acid, B) one or more structural units derived from substances of component b), the substances of component b) being selected from one or more compounds of the formula (I) R ² -O- (CH ₂ CH ₂ O) _u (C ₃ H ₆ O) _v (DO) _w -H (I) wherein R ^{2 is} a linear or branched, saturated alkyl group having 6 to 30, preferably 8 to 22, particularly preferably 12 to 18 carbon atoms, or a linear or branched, mono- or polyunsaturated alkenyl group having 6 to 30, preferably 8 to 22 , particularly preferably 12 to 18 carbon atoms, D is a linear or branched saturated alkylene group having 4 to 20 carbon atoms, a linear or branched mono- or polyunsaturated alkenylene group having 4 to 20 carbon atoms or -CH (aryl) CH ₂ - , preferably -CH (phenyl) CH ₂ -, u, u is a number from 0 to 200, preferably from 2 to 150, particularly preferably from 5 to 100, particularly preferably from 10 to 50, v is a number from 0 to 100, preferably from 2 to 50, particularly preferably from 5 to 20, w is a number from 0 to 100, preferably from 0 to 20, particularly preferably from 0 to 10, and wherein the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO C) one or more structural units derived from substances of component c), the substances of component c) being selected from one or more diols of the formula (II) embedded image in which the compounds of the formula (I) can be arranged blockwise or randomly distributed HO- (CH ₂ CH ₂ O) _a (C ₃ H ₆ O) _b (DO) _c -H (II) wherein D has the meaning as in formula (I), a is a number from 0 to 800, preferably from 0 to 250, more preferably from 10 to 200, and most preferably from 20 to 100, b is a number from 0 to 100, preferably from 0 to 50, c is a number from 0 to 100, preferably from 0 to 20, wherein the sum of a + b + c ≥ 1, preferably from 5 to 150, and the groups CH ₂ CH ₂ O, C ₃ H ₆ O and DO from the compounds of formula (II) may be arranged block-wise or randomly distributed and contain the phosphoric acid ester 2 or more via a structural unit derived from the compounds of formula (II) bridged P atoms per molecule. organophosphate according to claim 1, characterized in that at least 80%, preferably from 90 to 100%, and more preferably from 95 to 100% of the Substances of component a) theoretically maximum available esterifiable functions are esterified. organophosphate according to claim 1 or 2, characterized in that v and w in the structural units derived from the compounds of the formula (I) are 0. organophosphate according to one or more of claims 1 to 3, characterized that in the structural units derived from the compounds of the Formula (I) u of 1 to 150, preferably 5 to 100 and especially preferably from 10 to 50. organophosphate according to one or more of claims 1 to 4, characterized that b and c in the structural units derived from the compounds of the formula (II) are 0. organophosphate according to one or more of claims 1 to 5, characterized that in the structural units derived from the compounds of the Formula (II) a of 1 to 800, preferably 10 to 200 and especially preferably from 20 to 100. organophosphate according to one or more of claims 1 to 6, characterized that the one or more structural units derived from the one or more diols of the formula (II) are derived selected by Diolen from ethylene glycol, diethylene glycol, triethylene glycol, tetraethylene glycol, Polyethylene glycol (PEG) with molecular weights from 200 to 35000, preferably PEG 200, PEG 300, PEG 400, PEG 600, PEG 800, PEG 1000, PEG 1500, PEG 2000, PEG 3000, PEG 3350, PEG 4000, PEG 6000, PEG 8000, propylene glycol, dipropylene glycol, tripropylene glycol, polypropylene glycol, Polybutylene glycol, copolymers of ethylene oxide and propylene oxide with molecular weights from 200 to 35,000, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 1,2-pentanediol, 1,3-pentanediol, 1,4-pentanediol, 1,5-pentanediol, 1,2-hexanediol, 1,3-hexanediol, 1,4-hexanediol, 1,5-hexanediol, 1,6-hexanediol and 1,12-dodecanediol. Phosphoric acid esters according to one or more of claims 1 to 7, characterized in that the one or more structural units derived from the one or more compounds of formula (I) are structural units, wherein u is a number from 1 to 200, preferably from 2 to 150, particularly preferably from 5 to 100 and particularly preferably from 10 to 50, is, v and w are 0, and the radical R ² -O- is derived from alcohols selected from octanol, decanol, dodecanol, tetradecanol, hexadecanol, octadecanol, Eicosanol, behenyl alcohol, fatty alcohols with C chain cuts between 8 and 22, preferably C ₁₀ / C ₁₂ fatty alcohol, C ₁₂ / C ₁₄ fatty alcohol, C ₁₂ / C ₁₅ fatty alcohol, C ₁₆ / C ₁₈ fatty alcohol, branched Fatty alcohols, preferably Guerbet alcohols, monounsaturated fatty alcohols, preferably delta-9-cis-hexadecanol, delta-9-cis-octadecanol, trans-9-octadecanol and cis-delta-11-octadecanol. organophosphate according to one or more of claims 1 to 8, characterized that the total number of structural units contained in the phosphoric acid esters derived from the one or more compounds of the formula (I), preferably the total number of those contained in the phosphoric acid esters Structural units derived from the one or more compounds of the formula (I) wherein u is a number 1 to 200, preferably from 2 to 150, particularly preferred from 5 to 100, and more preferably from 10 to 50, and v and w are 0, from 4 to 20, preferably from 4 to 10 and particularly preferred from 4 to 6. organophosphate according to one or more of claims 1 to 9, characterized that the total number of ethylene oxide units contained in the phosphoric acid esters in the structural units derived from the substances of the component b) and the substances of component c) together per fatty alcohol end group resulting from the compounds of formula (I) from 30 to 100 and preferably from 40 to 80. Phosphoric acid esters according to one or more of claims 1 to 10, characterized in that the structural units derived from the substances of component a) are selected from structural units of the formulas (A1) to (A3)

wherein each M is independently H ⁺ or a counterion and the counterions are selected from Li ⁺ , Na ⁺ , K ⁺ , Mg ⁺⁺ , Ca ⁺⁺ , Al ⁺⁺⁺ , NH ₄ ⁺ and quaternary ammonium ions [HNR ¹ R ² R ³ ] ⁺ , wherein R ¹ , R ² and R ^{3 are} independently hydrogen, a linear or branched alkyl group having 1 to 22 carbon atoms, a linear or branched, mono- or polyunsaturated alkenyl group having 2 to 22 carbon atoms, a linear mono-hydroxyalkyl group having 2 to 10 carbon atoms, preferably a mono-hydroxyethyl or mono-hydroxypropyl group, as well as a linear or branched di-hydroxyalkyl group having 3 to 10 carbon atoms, and are preferably structural units of the formula (A1). organophosphate according to one or more of claims 1 to 11, characterized in that they are derived from structural units of the substances of the components a), b) and c) exist. Use of one or more of the phosphoric acid esters according to one or more of claims 1 to 12 as a thickener, Consistency regulator, emulsifier, sensory additive, solubilizer, dispersant, Lubricant, adhesive or stabilizer. Use of one or more phosphoric acid esters according to one or more of claims 1 to 12 in deodorant or antiperspirant formulations, especially in deodorant or Antiperspirant formulations containing aluminum salts, preferred Aluminum chlorohydrate or aluminum-zirconium complex salts to reduce formation white Residues on clothing after application of the deodorant or antiperspirant formulations on the skin. Cosmetic, pharmaceutical or dermatological Composition, characterized in that it contains one or more organophosphate according to one or more of claims 1 to 12 contains. Composition according to Claim 15, characterized that they are in the form of an aqueous, aqueous-alcoholic or aqueous surfactant composition, an emulsion, suspension, dispersion, a powder or a Sprays is present. A composition according to claim 15 or 16, characterized characterized in that it has a pH of 2 to 10, preferably from 2 to 6, more preferably from 2.5 to 5 and in particular preferably from 3 to 4.5. Composition according to one or more of claims 15 to 17, characterized in that it contains one or more electrolytes contains. Composition according to Claim 18, characterized that the content of the one or more electrolytes, based to the entire composition, from 0.1 to 20.0 wt .-%, preferably from 0.2 to 10.0 wt%, and more preferably from 0.5 to 5.0 Wt .-% is. Composition according to one or more of claims 15 to 19, characterized in that they hydrogen peroxide or hydrogen peroxide-releasing substances contains and preferably in the form of a gel. Composition according to one or more of claims 1 to 20, characterized in that it one or more organophosphate according to one or more of claims 1 to 12, based on the finished composition, in an amount of 0.01 to 10.0 wt .-%, preferably from 0.1 to 6.0 wt .-% and particularly preferably from 0.5 contains up to 3.0 wt .-%. Composition according to one or more of Claims 15 to 21, characterized that it contains one or more surfactants.